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ABBREVIATIONS
ABP  actin binding protein (general)
Abp1  actin binding protein 1
ADP  adenosinediphosphate
ADF  actin-depolymerizing factor
Aip1  actin-interacting protein 1
ATP  adenosinetriphosphate
Arp  actin related protein
cAMP  cyclic adenosine monophosphate
CAP  cyclase-associated protein
Cc  critical concentration
cc    coiled-coil domain
CH  calponin homology 
CP  capping protein
E  embryonic day
Ena/VASP enabled/vasodilator-stimulated phosphoprotein
ERM  ezrin/radixin/moesin
F-actin   fi lamentous actin
FH  formin homology
G-actin  globular actin (monomer)
GFP  green fl uorescent protein
GST  glutathione S-transferase
GTP  guanosine triphosphate
IF  intermediate fi lament 
NLS  nuclear localization signal
MAP  microtubule-associated protein
MT  microtubule
MIM  missing-in-metastasis
P1  fi rst polyproline-rich sequence
P2  second polyproline-rich sequence
PI(4,5)P2 phosphatidylinositol-(4,5)-bisphosphate
Pi  pyrophosphate, inorganic phosphate
Srv2  suppressor of RAS2-val19
WH2  WASP homology domain 2
WASP  Wiskott-Aldrich Syndrome Protein
ABSTRACT
The highly dynamic remodeling of the actin cytoskeleton is responsible for most motile 
and morphogenetic processes in all eukaryotic cells. In order to generate appropriate 
spatial and temporal movements, the actin dynamics must be under tight control of an 
array of actin binding proteins (ABPs). Many proteins have been shown to play a specifi c 
role in actin fi lament growth or disassembly of older fi laments. Very little is known about 
the proteins affecting recycling i.e. the step where newly depolymerized actin monomers 
are funneled into new rounds of fi lament assembly. A central protein family involved in 
the regulation of actin turnover is cyclase-associated proteins (CAP, also called Srv2 in 
budding yeast). This 50-60 kDa protein was fi rst identifi ed from yeast as a suppressor of 
an activated RAS-allele and a factor associated with adenylyl cyclase. The CAP proteins 
harbor N-terminal coiled-coil (cc) domain, originally identifi ed as a site for adenylyl 
cyclase binding. In the N-terminal half is also a 14-3-3 like domain, which is followed 
by central proline-rich domains and the WH2 domain. In the C-terminal end locates the 
highly conserved ADP-G-actin binding domain. 
In this study, we identifi ed two previously suggested but poorly characterized 
interaction partners for Srv2/CAP: profi lin and ADF/cofi lin. Profi lins are small proteins 
(12-16 kDa) that bind ATP-actin monomers and promote the nucleotide exchange of 
actin. The profi lin-ATP-actin complex can be directly targeted to the growth of the 
fi lament barbed ends capped by Ena/VASP or formins. ADF/cofi lins are also small 
(13-19 kDa) and highly conserved actin binding proteins. They depolymerize ADP-
actin monomers from fi lament pointed ends and remain bound to ADP-actin strongly 
inhibiting nucleotide exchange. We discovered that the ADP-actin-cofi lin complex is 
able to interact directly with the 14-3-3 like domain at the N-terminal region of Srv2/
CAP. The C-terminal high affi nity ADP-actin binding site of Srv2/CAP competes for 
an actin monomer with cofi lin. Cofi lin can thus be released from Srv2/CAP for the 
subsequent round of depolymerization. We also revealed that profi lin interacts with the 
fi rst proline-rich region of Srv2/CAP and that the binding occurs simultaneously with 
ADP-actin binding to the C-terminal domain of Srv2/CAP. Both profi lin and Srv2/CAP 
can promote nucleotide exchange of an actin monomer. Because profi lin has much 
higher affi nity to ATP-actin than Srv2/CAP, the ATP-actin-profi lin complex is released 
for fi lament polymerization. While a disruption of cofi lin binding in yeast Srv2/CAP 
produces a severe phenotype comparable to Srv2/CAP deletion, an impairment of 
profi lin binding from Srv2/CAP results in much milder phenotype. This suggests that 
the interaction with cofi lin is essential for the function of Srv2/CAP, whereas profi lin 
can also promote its function without direct interaction with Srv2/CAP. We also show 
that two CAP isoforms with specifi c expression patterns are present in mice. CAP1 is 
the major isoform in most tissues, while CAP2 is predominantly expressed in muscles. 
Deletion of CAP1 from non-muscle cells results in severe actin phenotype accompanied 
with mislocalization of cofi lin to cytoplasmic aggregates. Together, these studies suggest 
that Srv2/CAP recycles actin monomers from cofi lin to profi lin, and it therefore plays a 
central role in actin dynamics in both yeast and mammalian cells.
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The cytoskeleton is a fundamental structure for all cells. Without the cytoskeleton, 
cells would just be loose sacks fl oating around in their environment, unable to maintain 
their shape, to move, feed or divide. The cytoskeleton is a dense and seemingly random 
cytoplasmic network of different kinds of fi laments. They fi ll the space inside the cell 
and maintain the cell shape. Cytoskeletal components can generate mechanical forces: 
pushing, by arranging themselves into a certain direction, and pulling, by contracting 
along one another accompanied by loads of other proteins. These movements generate 
dramatic changes in cell shape needed for cell migration, endocytosis and cell division. 
The cytoskeleton also contributes to different kinds of translocation inside the cell by 
forming the tracks for motor proteins (Wade and Hyman, 1997, Godsel et al., 2008, 
Pollard and Borisy, 2003). In eukaryotic cells, the cytoskeleton is composed of three 
different fi lament types, microtubules, intermediate fi laments and microfi laments.
Figure 1. The cytoskeleton. Schematic picture illustrates the three components of the eukaryotic 
cytoskeleton. Microtubules (green) grow radial from centrosomes, plus- ends towards the plas-
mamembrane, growing and shrinking alternately. Intermediate fi laments (blue) localize around 
the cell and in the nucleus next to the inner nuclear membrane. Microfi laments (actin fi laments) 
(red) form fi brous structures to the growing front and to the shrinking tail of the cell. 
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Table 1. Cytoskeletal components. Cytoskeleton consists of three different fi lament types, 
microtubules, intermediate fi laments and microfi laments. The subunit proteins and general func-
tions are listed here.  
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Microtubules represent the widest cytoskeletal fi lament type, being 24 nm in diameter. 
Highly homologous globular α- and β-tubulin monomers form heterodimers. Both 
monomers bind guanosine triphosphate (GTP), but only the one bound to β-tubulin is 
hydrolyzed during polymerization. The α- and β-tubulin heterodimers self-assemble to 
polar oligomer, resembling a cylindrical tube (Fig.1)(Nogales et al, 2006). β-subunits 
point towards the fast-growing plus-end, whereas the α-tubulins point towards the minus 
end, which is typically connected to the centromere (Nogales et al., 1999). 
The organization and dynamics of microtubules are regulated by an array of 
microtubule-associated proteins (MAP)s, which can e.g. either stabilize or destabilize 
microtubules (Halpain and Dehmelt, 2006, Morrison, 2007). Recent studies have shown 
that also post-translational modifi cations play an important role in the regulation of 
microtubule function. α- and β-tubulin monomers can be acetylated, polyglycylated, 
polyglutamylated, tyrosinated, phosphorylated and palmitylated, which further increases 
microtubule diversity for variety of functions (Westermann and Weber, 2003).
Microtubules form a highly dynamic network inside the cell. The motor proteins 
dynein and kinesin can move along the microtubules and thus transport cargo across the 
cell (Caviston and Holzbaur, 2006). Microtubules also play a role in cell motility. The Rho 
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family GTPases, known to be key regulators in cell migration, contribute directly to the 
dynamics of microtubules by capturing and stabilizing them to the cell cortex (Watanabe 
et al., 2005). The most well characterized function of microtubules is the formation 
of the mitotic spindle, which drives chromosome segregation during cell division. The 
plus-ends of spindle microtubules attach to the kinetochore, which is a complex structure 
located at the centromere and is composed of >80 proteins. The dynamics of the spindle 
microtubules separates the daughter chromosomes after successful alignment of the all 
chromosomes and passing the spindle checkpoint (Cheeseman and Desai, 2008). 
The growing family of MAPs also includes many oncogenes, tumor suppressors and 
regulators of apoptosis. This, together with the central role microtubules in cell division 
and survival, makes microtubules and their associated factors promising targets for a 
variety of cancer therapeutic drugs (Bhat and Setaluri, 2007).  
2. Intermediate fi laments
The second cytoskeletal fi lament type is the intermediate fi lament (IF). The principal role 
of these approximately 10 nm wide fi laments is to maintain structural integrity. They also 
maintain the cell shape, position cell organelles, and organize cells to tissues by forming 
a variety of intercellular junctions. During cell division, intermediate fi laments have also 
a signaling role in cell cycle control. In neurons, intermediate fi laments are responsible 
for directionality of radial axon outgrowth (Herrmann et al., 2003, Coulombe and Wong, 
2004). 
Intermediate fi laments consist of ∼65 different proteins (Hesse et al., 2001). These 
proteins are expressed in distinct tissues and cell-types, depending on the structural and 
functional needs. Based on sequence homology, intermediate fi laments can be divided 
into fi ve classes listed in Table 1. In the general fi lament assembly model, the monomers 
fi rst form a dimer, then a tetramer. Tetramers interact laterally to form unit-length 
fi laments (ULFs), which can polymerize into long fi bers (Fig. 1) However, different 
intermediate fi laments display variations to this assembly model (Strelkov et al., 2003). 
Most IFs localize around the cytoplasm and form a rigid network supporting the 
cell under a mechanical stress, with an exception of the group V, lamins, which form a 
network inside the nucleus, next to the inner nuclear membrane. Lamins maintain the 
shape of the nucleus and play an important role during cell division (Haas and Jost, 
2003). Intermediate fi laments also have a structural function in positioning the cell 
organelles (Toivola et al., 2005)
Unlike globular G-actin and tubulin, intermediate fi lament monomers are composed 
of a rod shaped central domain accompanied with globular N- and C- terminal domains 
(Fuchs and Weber, 1994). The central domains, more precisely the dimerization sites, 
are usually relatively well conserved, whereas the distal domains are more variable and 
harbor also many phosphorylation sites. Intermediate fi laments are regulated through 
these specifi c phosphorylations. For example, during cell division or under certain cell 
stress, multiple phosphorylations of distal head domains induce depolymerization of 
the fi laments. This property is important for the function of the intermediate fi laments, 
which are thus rigid and relatively stable assemblies with a structural role, but can be 
quickly decomposed after adequate set of signals allowing the cell to undergo dramatic 
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Figure 2. Three-dimensional structure of G- and F-actin. Crystal-structure of G-actin 
(monomer) reveals the cleft between two lobes where the nucleotide, either ADP or ATP and a 
divalent cation bind. Actin monomers can polymerize into polar F-actin (fi lament). 
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changes in shape (Herrmann and Aebi, 2004). Mutations in the genes of intermediate 
fi laments contribute to more than 30 diseases including muscular dystrophies, premature 
aging and skin and end-stage liver diseases (Herrmann and Aebi, 2004).
3. Microfi laments
Third fi lament type is the thinnest and is therefore called microfi lament. These 7-9 nm 
wide fi laments consist entirely of actin, which is the most abundant protein in many 
eukaryotic cell types. Probably the best-known function of actin is its ability to form 
contractile muscular units, i.e. sarcomeres, with a motor protein myosin II (Eddinger 
and Meer, 2007). In all eukaryotic cells, from cell-walled yeast to non-muscle cells of 
higher eukaryotes, actin with its unique ability to form polar fi laments is responsible for 
a variety of important cellular functions, as discussed in the following chapters (Pollard 
and Borisy, 2003).
3.1. Actin
Actin monomer is a highly conserved 42-44 kDa globular protein consisting of two 
major domains which are further divided into four subdomains 1–4 (Kabsch et al., 
1990). Between the subdomains 2 and 4, there is a hydrophobic pocket which binds 
a nucleotide, either ADP or ATP (Fig.2). The ability to hydrolyze ATP and release the 
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inorganic phosphate (Pi) makes actin protein a functional ATPase. Inside the domains, 
there is also a divalent cation, either Ca2+ or Mg2+ (Kabsch and Holmes 1995). On the 
opposite side of the protein, between the subdomains 1 and 3, locates a small cleft 
known to be a target for most actin-binding proteins (ABPs)(Dominguez et al., 2004). 
The actin structure has been well studied, and the crystal structures of actin with an array 
of ABPs are available. The actin monomer is a fl exible protein with the ability to change 
conformation from closed to more open depending on the prevailing circumstances, 
status of the nucleotide, interacting ABPs, the nature of the cation or the degree of 
oligomerization (Moraczewska et al., 1999, Schüler, 2001).
3.2. Actin dynamics
The most important feature of actin monomer (also called G-actin) is its ability to 
form dimers and to further oligomerize into long fi laments called F-actin. In these 
structures, all actin monomers are facing into the same direction, thus forming a polar 
oligomer. Binding to other actin monomers also causes a conformational change within 
the monomers leading to altered biochemical properties. As a result, already the third 
monomer added to this growing filament has a preference to interact with certain 
end of the forming fi lament, called barbed or “fast growing” plus-end. The critical 
concentration (Cc) for polymerization at the barbed end is 0,1 μM under physiological 
ionic conditions. The other end is called pointed or “slow growing” minus-end and has 
a higher critical concentration for polymerization (Cc = 0,7 μM). In actin monomer 
concentrations between these two Cc´s, the barbed end favors filament formation 
(polymerization), whereas the actin monomers are dissociating from the pointed end. 
These differences cause actin pool never to fi nd an equilibrium between G- and F-actin, 
but instead being in the constant circle of simultaneous growing and shrinking at the 
barbed and pointed ends, respectively. This phenomenon is called actin treadmilling (Fig 
3.) (Wegner, 1982).
Figure 3. ”Treadmilling”. Actin monomers undergo constant circulation. Under steady-state 
conditions, ATP-actin monomers are added to the fi lament barbed end (+). In the fi lament, ATP is 
hydrolyzed to ADP, which leads to more unstable structure of the fi lament. From pointed end (-), 




The ability of actin monomers to bind to either ADP or ATP has important 
consequences in treadmilling. Filamentous actin has higher affinity to ATP-actin 
monomers than ADP-actin, so the monomers added to barbed ends are typically in the 
ATP-form (Pollard, 1986). In fi laments, ATPase activity of actin is increased dramatically 
and it hydrolyses the inorganic phosphate from ATP to generate ADP-actin, causing 
also a conformational change within the protein (Pollard and Weeds 1984). Because the 
equilibrium drives monomer dissociation from pointed ends and ADP-actin dissociates 
from fi lament ends even more effectively, treadmilling rates are further increased (Fig 
3.). The ability of actin to form fi laments and to rapidly arrange them under strict spatial 
and temporal regulation of ABPs generates most key functions of actin in yeast and 
mammalian cells (Pollard et al. 2000).
3.3. The actin cytoskeleton in budding yeast 
The actin cytoskeleton from budding yeast was fi rst demonstrated already in 1984 
(Kilmartin and Adams 1984, Adams and Pringle 1984). In Saccharomyces cerevisiae, 
actin is encoded by a single gene ACT1, which shows 80% sequence similarity with 
mammalian actin genes (Shortle et al., 1982). The structural and biochemical properties 
of yeast actin are also notably similar to those of mammalian actin proteins. However, 
the need for F-actin structures in a yeast cell which is supported by a cell wall is highly 
different from the situation in mammalian non-muscle cells which maintain their shape 
solely with internal cytoskeleton. 
In S.cerevisiae cells, F-actin staining visualizes three kinds of fi lamentous actin 
structures. The fi rst of these are cortical spots, called “patches” which are more or less 
round structures found at the cell periphery, at the plasma membrane or somewhere near. 
During budding, these patches are concentrated to the growing daughter cell (Fig. 4A). 
The second clear structures are long actin fi lament bundles, called “cables” coursing 
longitudinally through the cell, and the third one is the contractile ring forming during 
cell division. 
Early studies of yeast actin already suggested that the cortical patches were 
components of endocytic pathway (Kubler and Riezman 1993). This function was 
clarifi ed by studies with endocytic vesicles (marked with FM4-64) colocalizing with 
actin marker Abp1-GFP (Huckaba et al., 2003, Kaksonen et al., 2003). Nowadays, actin 
patch dynamics can be visualized by using GFP-tagged actin binding proteins, and real-
time movements can be recorded in living cells (Pelham and Chang 2001, Kaksonen 
et al., 2003). It is known that patches form on plasma membrane, move inward and 
disappear. Patch movement can be divided into three stages according to the speed of 
the patch and the actin-binding proteins present. At the fi rst stage, patches form and 
stay more or less non-motile near the membrane. In this stage, for example, the proteins 
Las17, Sla1, Sla2 and Pan1 are present (Kaksonen et al., 2005). A recent study also 
localized an endocytic vesicle protein clathrin in these structures (Newpher et al., 2005). 
At the second stage, polymerized actin appears, and the patch starts slow movement 
at the cortex (0,05 to 0,1 μm/s). At this stage, patches also contain Arp2/3, Abp1 and 
type I myosins, Myo3 and Myo5. These proteins contribute to actin fi lament assembly, 
accomplishing vesicle scission and generating pushing forces. At the third stage, the 
Introduction
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Figure 4. Actin structures in yeast and mammalian cells. (A) The yeast actin cytoskeleton 
consists of two structures visible by light microscopy: actin patches and actin cables. Patches 
are concentrated to the region of cell growth, whereas the cables usually course the cell 
longitudinally (B). Mouse heart muscle cell reveals the regular pattern of the actomyosin 
structures, called sarcomeres. (C) Mouse B16F1 melanoma cell have visible stress fi bers, wide 
smooth lamellipodium, and several fi lopodia pointing out from lamellipodium. (D) Contractile 
ring in dividing NIH3T3 fi broblast.
patch starts fast, actin cable-based movement inward from the cortex (0,3 μm/s). Many 
early components are shed (Las17, Sla1, Sla2, Pan1, Myo3 and Myo5), while some actin 
binding proteins still remain associated with these structures (Kaksonen et al., 2005). 
At the last, rapid movement stage, endocytic patches move along actin cables. 
Actin cables are long directed actin bundles coursing the cell (Fig. 4A). Yeasts use these 
structures for polarized growth and as tracks for carrying cargo (Bretscher, 2003). These 
functions are closely related, the unbudded cells use the landmarks remaining from the 
previous budding events to orientate barbed ends of the actin cables towards to the new 
bud site and form polarity to direct next budding cycle (Moseley and Goode, 2006). Actin 
cables are polymerized by yeast formin-family proteins, Bni1 and Bnr1 (Evangelista et 
al., 2002). Along these roughly parallel actin bundles, cells deliver organelles and cargo 
vesicles to daughter cells. Vesicles contain material for growth of the bud and are mainly 
delivered by type V myosins, Myo2 and Myo4 (Schott et al., 2002). 
Introduction
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The third, clearly separable actin structure in yeast cell is called actomyosin ring. 
This ring appears around the bud neck only during the late anaphase stage of the 
cell division. (Bi et al., 1998, Lippincott and Li, 1998). The ring is formed in Arp2/3 
dependent manner, and the contraction is generated by the interaction of actin fi laments 
with type II myosin, Myo1 (Winter et al., 1999, Watts et al., 1987).  
3.4. The actin cytoskeleton in mammalian cells 
Mammals have at least six genes that code actin (Vandekerckhove et al., 1978). They are 
divided into three groups based on their electrophoretic mobility, to α-, β- and γ-actins. 
These actin isoforms are selectively expressed in different tissues and cell types, four in 
skeletal muscles and β- and γ-actins mainly in non-muscle cells. These actin isoforms 
are >95 % identical to each other at amino acid level, and their biochemical properties 
are comparable. In mammalian cells, there are two types of actin-based movements. In 
the fi rst type, the force is generated by motor protein myosin moving along the actin 
fi laments. Such myosin driven forces play an important role in contraction of muscle 
sarcomeres (Fig. 4B) and stress fibers of non-muscle cells (Fig. 4C) as well as in 
contractile ring during cell division and in vesicle transport in endo- and exocytosis 
(Fig. 4D). In the second type, the movement results from growing fi lament barbed ends 
pushing the cellular membrane, for example during the formation of plasma membrane 
protrusions in cell migration (Fig. 4C) (Pollard and Borisy et al., 2003). 
Muscle cells have developed to carry out whole-cell contraction and generate forces 
to move the entire organism. In muscle cells, actin is arranged with motor protein type 
II myosin (together called actomyosin) into highly ordered structures i.e. sarcomeres 
(Fig. 4B). In order to form a functional muscle, sarcomeres must follow a continuous 
pattern throughout the cell and be fi rmly attached to the sarcomeres of the adjacent cell 
(Eddinger and Meer, 2007). Actin dynamics of mature muscle cells is highly different 
from that seen in non-muscle cells because most of the actin is reserved for these stable 
patterns. Nevertheless, also muscle cells contain a pool of “free” and dynamic actin 
which is perhaps responsible for other actin-based functions.
Staining of cultured non-muscle cells with an actin-binding drug phalloidin shows, 
most visibly, thick fi bers coursing the cell (Fig. 4C). These structures are called stress 
fi bers, and they are contractile actomyosin bundles responsible for maintenance of 
cell stiffness and contraction of the trailing edge during cell migration. Stress fi bers 
are covered periodically by two proteins, α-actinin (bundling) and type II myosin 
(contraction). Stress fi bers can be divided into three subtypes: ventral stress fi bers must 
be attached to focal adhesions from both ends to generate forces to retract cell; dorsal 
stress fi bers attached to the focal adhesions at one end in the growing lamellipodia, and 
transverse arcs, which are not directly attached to focal adhesions (Pellegrin and Mellers, 
2007). A resent study revealed that dorsal stress fi bers and transverse arcs are precursors 
of ventral stress fi bers (Hotulainen and Lappalainen, 2006).      
In motile animal cells, actin forms a structure called lamellipodium (Fig. 4C). 
Lamellipodium is a wide, dense network of branched actin fi laments (Pollard and Borisy, 
2003). It is formed to the edge of the cell, and it pushes the cell membrane forward 
during cell migration. In order to generate constant pushing force, lamellipodium must 
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simultaneously decompose from the back and funnel the released actin monomers to the 
growing front line. A core set of proteins involved in the formation of lamellipodium 
includes actin, Arp2/3 complex, profi lin, capping protein (CP) and ADF/cofi lins (Mullins 
et al., 1998, Svitkina and Borisy 1999). Other structures related to lamellipodia include 
fi lopodia (Fig. 4C). These fi ngerlike protrusions consist of parallel unipolar bundles of 
actin fi laments pointing out from the cell edge (Gupton and Gertler, 2007). In fi lopodia, 
there are no Arp2/3-based branched fi laments. Instead, the nucleation and processive 
capping of actin fi laments in fi lopodia is achieved by Ena/VASP- and formin –family 
proteins (Bear et al., 2002, Schirenbeck et al., 2005).
3.5. Actin in human diseases
Actin and actin-binding proteins play a central role in various cellular processes, and 
consequently mutations of these proteins are often associated to specific diseases. 
Mutations in skeletal α-actin gene (ACT1) in humans cause three different kinds of 
myopathies: actin myopathy (AM), intra-nuclear rod myopathy (IRM) and nemaline 
myopahy (NEM). The histopathological phenotype shows an accumulation of abnormal 
F-actin rods in muscle cells, and the clinical phenotype includes severe congenital 
muscle weakness and high mortality. More than 80 different point mutations in ACT1 
gene have been characterized to cause these diseases and usually these mutations disrupt 
specifi c actin interactions within the sarcomere structure (Sparrow et al., 2003). Only 
few pathological phenotypes have been demonstrated for mutations in other actin genes. 
Point mutations in cardiac α-actin gene (ACTC) can cause hypertrophic cardiomyopathy 
(Mogensen et al., 2004) whereas a specifi c mutation in non-muscle β-actin has been 
reported to alter depolymerization dynamics of actin and lead to developmental 
malformations, deafness and dystonia (Procaccio et al., 2006). 
Actin interacts with a huge amount of proteins and also mutations in these can 
cause a plethora of actin-related sicknesses. Mutations in several actin-binding proteins, 
including α-actinin, nebulin, titin, ADF/cofi lin, and tropomyosin have been linked to 
congenital myopathies (Laing, 2007). Disruption of ADF/cofi lin’s normal function in 
actin dynamics was also suggested play a role in several pathophysiological defects 
including Alzheimer’s disease and ischemic kidney disease (Bamburg and Wiggan, 
2002).
3.6. Actin binding proteins 
Actin structures are regulated by numerous actin-binding proteins (ABPs). Some of 
them have a structural role, connecting fi laments with one another (bundling, cross-
linking etc.), to intracellular structures (organelles, vesicles, microtubules etc.), to 
plasma membrane, and through different kind of adhesions to environment (other cells, 
extracellular matrix, etc.). In addition, many ABPs function to mediate specifi c signals to 
modify actin structures. Although a plethora of ABPs is wide, actin interactions of these 
proteins are mediated through relatively few actin-binding domains. Six most ubiquitous 
actin binding motifs are the calponin homology (CH) domain, the WASP homology 2 
(WH2) domain, the gelsolin homology domain, the actin-depolymerizing factor (ADF) 
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homology domain, the formin homology 2 (FH2) domain and the myosin motor domain 
(Gimona et al., 2002, Paunola et al., 2002, Lappalainen et al., 1998, McGough et al., 
2003, Higgs et al., 2005, Sellers et al., 2000).
3.6.1. ABPs in actin dynamics
In the cells, the actin monomer concentration is high, even 100 μM, driving effi ciently 
towards fi lament polymerization. Certain proteins, for example β-thymosins sequester 
effi ciently actin monomers in 1:1 molar ratio, and thus maintain a pool of unpolymerized 
actin monomers. Monomers can be released to polymerization after suitable signals 
(Pollard and Borisy, 2003). The initial step in actin fi lament growth is called nucleation. 
This step takes place spontaneously, but can be greatly accelerated by nucleators such 
as formins and Arp2/3. Depending on the protein, the newly formed actin fi laments 
can occur in parallel or branched conformation (Mullins et al., 1998, Vavylonis et al. 
2006, Krause et al., 2003). Actin fi laments continue to grow from their barbed ends 
as long as ATP-actin monomers are available. Small actin-binding protein, profi lin, 
promotes nucleotide exchange of ADP-actin monomers and maintains adequate ATP-
actin monomer pool (Witke et al. 2004). 
Due to certain signals actin fi laments either grow or are capped by various capping 
proteins (Wear et al., 2003, McGough et al., 2003). Unwanted actin filaments are 
severed and depolymerized from pointed ends by ADF/cofi lins to maintain the pool of 
actin monomers (Bamburg et al., 1999). However, structurally important actin fi laments 
can be stabilized by for example tropomyosins (Blanchoin et al., 2001), attached to 
membrane by ERM-proteins (Niggli and Rossy, 2007), or to other actin fi laments by 
actin cross-linking proteins such as α-actinin and fi lamin (Edlund et al., 2001, Popowicz 
et al., 2006). With motor protein myosin, actin fi laments can also be used for intracellular 
traffi cking and can promote contraction of the cell (Eddinger and Meer, 2007, Sellers, 
2000). Table 2. shows a general overview of the actin binding proteins and their 
functions. Out of these proteins only profi lin, ADF/cofi lin and Cyclase-associated protein 
(CAP) are discussed here in more detail, because of their relevance in this study.
3.6.2. Profi lin
One of the essential actin monomer binding proteins was originally identified as 
a DNAase inhibitor that co-crystalizes with actin (Lindberg 1966, Lazarides and 
Lindberg 1974). Later, it was named profi lin according to its capability to keep actin 
in a monomeric or “profi lamentous” form (Carlsson et al., 1977). Profi lin is a small 
(12-16 kDa) ubiquitous ATP-actin binding protein, and it can be found in a plethora 
of organisms, for example in yeast (Oechsner et al., 1987), fl ies (Cooley et al., 1992) 
and plants (Valenta et al., 1991). Lower organisms, such as yeast, have only one gene 
encoding profi lin (Magdolen et al., 1988). An ameba Dictyostelim discoideum is an 
exception, since it has three profi lin-coding genes, two of which have been characterized 
in detail (Haugwitz et al., 1991). The number of profi lin-coding genes seems to be 
larger in higher species, for example mammals have fi ve: profi lin I, IIa, IIb, III and 
IV. In general, the different isoforms have evolved to fulfi ll the needs of various cell 
Introduction
11
Table 2. Actin binding proteins. Some examples of the central actin binding proteins are 
presented here. Proteins are classified by their functions. Numbers after the protein name 
indicate the actin binding domain of the protein; 1. The calponin homology (CH) domain. 2. 
The WASP homology domain (WH2) domain. 3. The gelsolin homology domain. 4. The actin-
depolymerizing factor (ADF) homology domain. 5. The formin homology 2 (FH2) domain 6. The 
myosin motor domain.
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types of multicellular organisms. Although the functional properties and structure of 
profi lins seem to be highly conserved, sequence similarities between different profi lins 
are surprisingly low (Witke et al., 2004). The crystal-structures of profi lin revealed a 
seven-stranded anti-parallel β-pleated sheet with two α-helices derived from N- and 
C-terminal sequences on the top and two other α-helices on the bottom side of the plate 
(for structure see Fig.6)(Schutt et al., 1993, Cedergren-Zeppezauer et al., 1994). 
3.6.2.1. Biochemical properties of profi lin
Biochemically, profi lin interacts with actin monomers, preferring ATP-actin (Kd ≈0,1 
μM) over ADP-actin (Kd ≈0,5 μM), polyprolines and phosphatidylinositol-(4,5)-
bisphosphate (PIP2) (Lu and Pollard, 2000, Lassing and Lindberg, 1985). Upon binding 
to actin monomer, many profi lins accelerate the rate of nucleotide exchange by more than 
1000-fold and stay bound to ATP-actin monomers (Mockrin et al., 1980, Goldscmidt-
Clermont 1992). Formins, a family of processive filament cappers, can use these 
profi lin-actin complexes for barbed-end growth. Formins contain proline-rich region, 
which binds profi lin with relatively high affi nity (Suetsugu et al., 1998, Vavylonis et 
al., 2006). The ability of profi lins to bind polyproline sequences has been known for 
long (Lindberg et al., 1988). Nowadays, more than 50 new ligands for profi lin have 
been characterized, among many formins (Witke et al., 2004). The binding surface for 
polyproline locates in the C-and N-terminal α-helices of profi lin, whereas the actin-
binding site lies on the opposite side of the molecule. This suggests that profi lin can bind 
these ligands simultaneously (Mahoney et al., 1997). Profi lin is also known to interact 
with phosphatidylinositol-(4,5)-bisphosphate (PIP2) trough two separate binding sites. 
The other binding site overlaps with the actin binding site, leading to dissociation of 
actin in the presence of PIP2 (Lassing and Lindberg, 1985). Other PIP2 binding site is 
interlaced with polyproline binding surface and PIP2 binding is thus also suggested to 
perturb interaction between profi lin and proline-rich sequences (Lambrechts et al., 2002, 
Skare and Karlsson, 2002). These functions make PIP2 a central inhibitory element in the 
regulation of profi lin function. 
3.6.2.2. Physiological role of profi lin
In all organisms studied, deletion of profilin yields a lethal or severely impaired 
phenotype with growth defects and visible actin disorganization. In yeast Saccharomyces 
cerevisiae, severe phenotypes in profi lin null (pfy1Δ) and point mutant strains, having 
a defect in actin binding (e.g. pfy1-4), show the importance of profi lin, and especially 
its actin binding property, for growth, morphology and actin organization (Hareer et al., 
1990, Wolven et al., 2000). It also seems that an important function of yeast profi lin in 
vivo is its capability to accelerate actin’s nucleotide-exchange rate and promote actin 
turnover. This is further supported by the observation that the cellular defects of pfy1-4 
can be rescued with actin mutant having increased intrinsic rate of nucleotide exchange 
(act1-15) (Wolven et al., 2000). In mammalian cells, profi lins localize to the sites of 
rapid actin remodeling, for example to the cell periphery, but also to the nucleus and 
the perinuclear area (Buss et al., 1992). Profi lin-1 knockout mice arrest at early stages 
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of development suggesting an importance for profi lin function also in mammalian cells 
(Witke et al., 2001).
3.6.3. ADF/cofi lin 
ADF/cofi lins are small (13-19 kDa) actin binding proteins. These proteins were initially 
identifi ed as actin-depolymerizing factor (ADF) and cofi lamentous (cofi lin) agent from 
chick and porsine brain, respectively (Bamburg et al., 1980, Maekawa et al., 1984). 
Subsequentially, ADF/cofi lin genes have been identifi ed from all eukaryotic organisms 
studied (e.g. Iida et al., 1993, Gunsalus et al., 1995, McKim et al., 1995). In the budding 
yeast, there is only one cofi lin gene (COF1), whereas in mammals, there are three 
isoforms, cofi lin-1, cofi lin-2 and ADF expressed (Moon et al., 1993, Vartiainen et al., 
2002). The structure of cofi lin reveals a four-stranded mixed β-sheet sandwiched between 
two pairs of α-helices. Loop regions combining secondary structure elements perform 
most of the variability between cofi lin isoforms (for structure see Fig.6)(Hatanaka et al., 
1996, Fedorov et al., 1997). 
3.6.3.1. Biochemical properties of ADF/cofi lins
ADF/cofi lins bind both monomeric and fi lamentous actin, preferring ADP-actin over 
ATP-actin. The main function of cofi lin is to depolymerize actin fi laments from their 
pointed ends. This is a rate-limiting step in actin treadmilling. As a result actin turnover 
can occur 25-fold faster in the presence of ADF/cofi lin in vitro (Carlier et al., 1997). 
On the other hand, ADF/cofi lin, when bound to monomeric actin, inhibits spontaneous 
nucleotide exchange and may actually, under certain concentrations, decelerate 
treadmilling (Hawkins et al., 1993). Amino acids responsible for actin interactions form 
two separate binding sites around the helix number three. One of them is responsible for 
actin monomer binding, whereas the other one binds an adjacent actin subunit during 
interaction with actin fi lament (Lappalainen et al., 1997). Binding of ADF/cofi lin to F-
actin changes the twist of actin fi lament by ∼5° between two actin monomers and the 
resulting thermodynamic change is believed to lead to enhanced fi lament severing and 
dissociation of subunits from pointed end (McGough. et al., 1997). ADF/cofi lin also 
binds to phosphatidylinositol-(4,5)-bisphosphate (PI(4,5)P2) through residues lying next 
to the actin binding surfaces, thus producing an effective negative regulation for cofi lin´s 
actin binding (Yonezava et al., 1991). As another regulatory element, ADF/cofi lin 
harbors conserved phosphorylation site in the far N-terminus (Ser3 in animal ADF/
cofi lins). Phosphorylation dramatically (20-30 fold) decreases ADF/cofi lin´s affi nity to 
actin (Ressad et al., 1998). ADF/cofi lin have a nuclear localization sequence (NLS), but 
the possible role of this characteristic remains elusive (Matsuzaki et al., 1988). 
14-3-3 proteins form a large group of highly conserved approximately 30 kDa 
proteins. These dimeric proteins are widely expressed in different organisms and tissues. 
14-3-3 proteins have reported to be involved in cell signaling, cell cycle progression, 
intracellular trafficking, cytoskeletal regulation and transcription. The interactions 
between these proteins with their ligands are usually highly specifi c and infl uenced by 
phosphorylations of the ligand and the dimerization of the 14-3-3 protein (Aitken et 
al., 2006). Phosphorylated ADF/cofi lins have been proposed to interact with a 14-3-3 
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protein family member 14-3-3ζ, but the physiological role of this interaction has not 
been studied (Birkenfeld et al., 2003). 
3.6.3.2. Physiological roles of ADF/cofi lins
A deletion of cofi lin gene from yeast Saccharomyces cerevisiae is lethal (Moon et al., 
1993). A systematic screen of point mutations in yeast COF1 gene revealed the in vivo 
importance of functions determined biochemically. As expected, actin binding and 
depolymerization activities are important for yeast growth and normal actin distribution. 
Nevertheless, dramatic in vivo phenotypes of two yeast cofi lin mutants (Cof1-5 and 
Cof1-9) cannot be explained by defects in actin binding. Thus, in addition to actin 
binding, also other protein interactions appear to be essential for the function of cofi lin 
in yeast (Lappalainen et al., 1997).
In cultured mouse fi broblasts, cofi lin-1 localizes to the sites of rapid actin turnover 
for example to lamellipodia (Yonezawa et al., 1987). Knocking down the cofi lin-1 
and/or ADF (cofi lin-2 is not expressed in these cells) causes increased content of F-
actin structures and disrupts actin-based functions such as cell migration and division 
(Hotulainen et al., 2005). Regardless of the biochemical, structural and cell biological 
similarity of mouse ADF/cofilin isoforms, the expression patterns and knockout 
phenotypes reveal some diversity among these proteins in mammals. Cofi lin-1 mRNA 
is uniformly expressed already during development at E9.5 and subsequently in all 
adult tissues with an exception of skeletal muscles. Cofi lin-2 mRNA, in addition to 
being expressed in heart, liver and testis, is the only isoform expressed in adult skeletal 
muscles. On the other hand, mRNA of ADF is mainly found in brain and epithelial tissues 
during late embryonic stages and in adult mice (Vartiainen et al. 2002). Transgenic mice 
lacking cofi lin-1 die at E10.5 as a result of an inability to close the neural tube (Gurniak 
et al., 2005), whereas ADF knockout mice are viable, but develop irregular thickening 
of the corneal epithelium and become blind before reaching the age of one month (Ikeda 
et al., 2003). 
3.6.4. Cyclase-associated protein (CAP)
One of the essential proteins regulating actin cytoskeleton in both yeast and mammalian 
cells are the cyclase-associated proteins (CAPs), also called Srv2 in budding yeast 
(In “introduction” referred to only as CAP). These proteins were originally found 
from budding yeast as a suppressor of Ras allele (Fedor-Chaiken et al., 1990) and in 
another study as a part of the adenylyl-cyclase complex (Field et al., 1990). Afterwards, 
homologues of CAP have been identifi ed from all organisms studied (e.g. S.pombe: 
Kawamukai et al., 1992, Dictyostelium discoideum: Gotwald et al., 1996, Mouse: Votjek 
and Cooper 1993, Rat: Zelicof et al.,1999, Pig: Gieselmann and Mann 1992, Human: 
Mattviw et al., 1992, Arabidopsis thaliana: Barrero et al., 2002). A second CAP isoform 
has also been identifi ed from rat and humans and named CAP2 (Swiston et al., 1995, 
Yu et al., 1994, Hubberstey et al., 1996). In general, CAP1 orthologues in animals share 
high degree (90%) of sequence identity to each other, while CAP2 proteins show only 




3.6.4.1. Biochemical properties of CAP
CAPs are 54-56 kD proteins with a highly conserved domain structure (Fig. 5). In the 
N-terminal end, there is a conserved coiled-coil (cc) structure known to mediate the 
adenylyl cyclase binding in yeast (Nishida et al., 1998) the importance of which was 
long considered controversial (Wang et al., 1995). This interaction was subsequently 
confi rmed and CAP was suggested to form another Ras-binding site to adenylyl cyclase 
and mediate Ras-dependent activation (Shima et al., 1999). CAP has been proposed to 
also function as an important link in Ras-signaling induced apoptosis in Saccharomyces 
cerevisiae (Gourlay and Ayscough 2006). Interaction with adenylyl cyclase is not 
conserved in mammals, most likely due to the differences between adenylyl cyclases 
of yeast and mammals (Hubberstey and Motillo, 2002). Although the CAP proteins 
have also been linked to cAMP signaling and adenylyl cyclase also in Dictyostelium 
discoideum (Noegel et al., 2000, 2004), a possible interaction of Ras with mammalian 
CAP remains elusive. 
After the coiled-coil domain follows the N-terminal domain, the function of which 
remains a mystery. This domain harbors the most diverse sequences in CAP proteins 
between the different species. The NMR structure of this domain (amino acids 51-226 
in D.discoideum CAP) reveals six antiparallel helices (for structure see Fig.6)(Ksiazek 
et al., 2003, Mavoungou et al., 2004). Biochemical studies showed strong antiparallel 
dimerization of positively charged clusters on the surface of helices number 4 (Yosof et 
al. 2005, 2006). The structure of the N-terminal domain resembles 14-3-3 domain, which 
is known to interact with phosphoserine containing proteins like cofi lin (Aitken, 2006, 
Birkenfi eld et al., 2003). Biochemical studies propose that human CAP may indeed 
interact with cofi lin through its N-terminal domain and accelerate cofi lin-dependent 
actin turnover (Moriyama and Yahara, 2002). However, the mechanism and possible 
biological relevance of this interaction remains to be shown.
In the middle region of the CAP protein, there are two proline-rich regions. The fi rst 
one, being highly conserved, harbors still unknown function, while the second one is 
responsible for correct subcellular localization of the CAP1 in yeast trough interaction 
Figure 5. The domain structure of Srv2/CAP. The N-terminal end of Srv2/CAP contains the 
coiled coil structure, followed by the N-terminal 14-3-3 like domain. The middle region of Srv2/
CAP harbors two proline-rich domains and WH2 domain between them. In the C-terminal end 
of Srv2/CAP locates a highly conserved ADP-G-actin binding domain. Previously suggested, but 
not confi rmed, functions of the domains are marked in to the fi gure with question marks.  
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with SH3 domain of Abp1 (actin-binding protein 1). Abp1 localizes to cortical actin 
cytoskeleton through direct interaction with actin fi laments (Freeman, 1996, Lila and 
Drubin, 1997, Yu et al., 1999). However, Abp1 appears not to bind CAP in mammalian 
cells, probably due to low sequence conservation of the second proline-rich region, the 
factor responsible for correct sub-cellular localization of CAP in mammals remains 
to be identifi ed. Studies with synthetic peptides and a high throughput yeast 2-hybrid 
screen suggest that CAP may also interact with profi lin through its polyproline regions 
(Lambrech et al., 1997, Drees et al., 2001). Between the proline-rich regions lies the 
WH2 domain. In other proteins, WH2 domains are known to bind actin monomers 
(Paunola et al., 2002), but at least in yeast Srv2/CAP, this domain does not contribute to 
the actin binding (Mattila et al., 2004)
The highly conserved C-terminal domain of CAP binds actin monomers and strongly 
inhibits actin polymerization (Freeman et al., 1995). The monomer sequestering activity 
of Dictyostelium CAP has also been proposed to be inhibited by PIP2, but only in the 
presence of N-terminal domain (Gottwald et al., 1996). The C-terminal domain of CAP 
prefers ADP-actin monomers (Kd 0,02-0,05 μM) over ATP-actin (Kd 1,9 μM) (Mattila 
et al., 2004) and it has also been observed to facilitate fi lament elongation at the barbed 
end by stimulating ADP/ATP-exchange on actin monomers (Moriyama and Yahara, 
2002). Crystal-structure of the domain (amino acids 370-526 of S.cerevisiae Srv2/CAP) 
revealed six coils of right-handed β-helix fl anked by antiparallel β-strands. This domain 
forms an unusual dimer by domain swapping of the last stands of each monomer (for 
structure see Fig.6)(Dodatko et al., 2004). A mutation analysis revealed an actin binding 
surface locating at the C- terminal end of the β-strand structure (Mattila et al., 2004). 
Most biochemical studies so far have been carried out with purifi ed domains of CAP. 
Many laboratories have reported dramatic problems, aggregation and autoproteolysis, 
while trying to purify the full length CAP (see e.g. Ksiazek et al., 2003). First insights 
into the function of full-length protein were reported during this thesis study. CAP was 
proposed to function as a multimeric complex and enhance actin turnover by recycling 
actin monomers and cofi lin (Moriyama and Yahara, 2002, Balcer et al., 2003). 
  
3.6.4.2. Biological role of CAP
Already in the fi rst studies concerning this protein, CAP was noticed to be important 
for actin organization in yeast (Fedor-Chaiken et al., 1990). Saccharomyces cerevisiae 
Srv2/CAP localizes to patch-like structures that partially overlap actin patches (Freeman 
et al., 1996). Mutants lacking Srv2/CAP displayed four phenotypes that appear to be 
unrelated to Ras-signaling, the inability to grow on rich medium (YPD), temperature 
sensitivity on minimal medium, sensitivity to nitrogen starvation, and swollen cell 
morphology (Field et al., 1990). In light microscopy analysis, Srv2/CAP mutants also 
showed depolarized actin patches and diminished actin cables. The phenotype of Srv2/
CAP deletion in yeast can be partially rescued by expression of profi lin (Votjek et al., 
1991), which together with the biochemical data suggests that these two proteins may 
have a functional link. Loss of CAP from Dictyostelium discoideum results in altered 
cell morphology, development and motile behavior (Noegel et al., 1999). Later, CAP 
was also found to play an important role in endocytosis of Dictyostelium discoideum 
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through direct interaction with the N-terminal half of CAP and V-ATPase (Sultana et al., 
2005).
CAP proteins are likely to display similar activities in plants. High functional 
homology is suggested by studies in which yeast CAP deletion is rescued by Arabidopsis 
thaliana CAP1 and over-expression of CAP in tobacco plants causes severe growth 
defects (Barrero et al., 2002, 2003). Deletion of CAP from Arabidopsis t. causes 
decreased germination effi ciency of pollen and actin fi lament disruption in the growth 
zone of the root hairs (Deeks et al., 2007). Plant CAPs were also reported to bind actin 
similarly to yeast and mammalian proteins (Barrero et al., 2002). Interestingly, later 
studies suggest that Arabidopsis t. CAP can promote nucleotide exchange of actin, but 
unlike yeast CAP, it has equal affi nity to both ATP- and ADP-actin monomers (Chaudry 
et al., 2007). 
In Drosophila, loss of CAP results in uncontrolled actin polymerization in 
developing oocytes, causing problems in cell polarity and proper asymmetric distribution 
of mRNA determinants (Baum et al., 2000). CAP has an important role also later in 
development, because it prevents excess actin polymerization in developing eyedisc 
(Benlali et al., 2000). These studies suggest the role of CAP in sequestering actin 
monomers and preventing polymerization rather than promoting it. 
In mammalian cells, CAP1 was initially observed to localize to membrane ruffl es 
and actin stress fi bers. In contrast to fi ndings in Drosophila cells, microinjection of 
purifi ed CAP induced formation of stress fi ber-like fi laments in serum starved Swiss 
3T3 cells (Freeman and Field, 2000). The role of CAP in mammalian cells has not been 
comprehensively demonstrated and this analysis is further complicated by the presence 
of two isoforms. However, these isoforms may be tissue specifi c, because rat CAP1 and 




AIMS OF THE STUDY
CAP protein was initially identifi ed from budding yeast in the year 1990 (Fedor- Chaiken 
et al., 1990, Field et al., 1990).  However, the role of CAP in cytoskeletal dynamics has 
been largely unknown. In addition to G-actin, CAPs have been suggested to interact 
with profi lin and ADF/cofi lin, but the physiological roles and mechanisms of these 
interactions were not known.
The aims of this study were:
-  To dissect the mechanisms by which CAP interacts with profi lin and ADF/cofi lin, as 
well as to map the binding sites of these proteins in CAP.
-  To study the importance of profi lin and ADF/cofi lin interactions of CAP in yeast.
-  To reveal the expression patterns and biological roles of the two mouse CAP 
isoforms.
-  To generate a model for how CAP contributes to actin dynamics.
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MATERIALS AND METHODS
The methods used in this study are listed below. The detailed descriptions can be 
found from original publications at in the end of this thesis. The roman numbers of the 
publications are indicated after the method. 
Method      Publication
Actin binding assay (NBD-assay)   I, II
Cloning and plasmid construction   I, II, III
Culture and transfection of mammalian cells  III
FRAP (Fluorescent recovery after photobleaching) III
Generation and affi nity purifi cation of antibodies III
Immunofl uorescence of mammalian cells  III
Labeling actin with NBD    I, II
Latrunculin A-assay     III
Light-microscopy techniques    I, III
Northern blot-analysis     III
Purifi cation of rabbit muscle actin    I, II
Recombinant protein expression and purifi cation  I, II, III
SDS-PAGE      I, II, III
Supernatant depletion pull-down assay   I, II
Tryptophan fl uorescence assay    I
Radioactive in situ-hybridization   III
RNAi-methods      III
Western blotting     I, III 
Yeast immunofl uorescence    I
Yeast co-immunoprecipitation    I
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Table 3. Yeast strains used in this study. Here are listed all phenotypes of yeast strains and 
features of the mutant proteins used in the original publications included in this thesis.
Name Mutation Phenotype Feature Reference
Srv2/CAP
SRV2 None Wild-type Wild-type Freeman et al., 
1996
Srv2Δ Deletion Severe actin and 
growth phenotype
Srv2/CAP null Gerst et al., 1991
Srv2-201 P278A, P279A, 
P280A
Enlarged cell size Profi lin binding I





Srv2-91 R202A, L204A, 
K205A, E206A 





Srv2-92 R208A, E209A, 
D211A
Wild-type Not tested II
Srv2-93 E216A, K219A,
K220A 
Wild-type Not tested II
Srv2-94 K233A, K234A Wild-type Wild-type II
Srv2-ΔCC Deletion of 
residues 1-50
Actin and growth 
phenotype
Hexamerization II
Srv2-Δ1-72 Deletion of 
residues 1-72




Pfy1-4 K66A Conditional (25-34°C) Actin binding Wolven et al., 
2000
Pfy1-14 Y119A, Y125A Conditional (25-34°C) Polyproline 
binding
Wolven et al., 
2000
Cofi lin












Cof1-19 R109A, R110A Wild-type  Not tested Lappalainen et 
al., 1999
Aip1
Aip1Δ Deletion Thickened actin 
cables





4. Characterization of Srv2/CAP-profi lin interaction (I)
Profi lin is known to interact with polyproline stretches, and Srv2/CAP harbors two of 
them in the central region of the protein. Direct interaction between these two proteins 
was previously suggested in high throughput yeast-2-hybrid assays and by studies using 
synthetic peptides (Lambrech et al., 1997, Drees et al., 2001), but the mechanism and in 
vivo role of this possible interaction had not been investigated.
4.1. Srv2/CAP interacts directly with profi lin.
In order to study the possible interaction between Srv2/CAP and profi lin, we purifi ed 
recombinant profi lin and C-terminal fragment of the Srv2/CAP containing proline-rich 
central domains and C-terminal actin-binding domain. We carried out a series of pull-
down assays and revealed that these proteins, indeed, do interact with each other in vitro. 
In order to determine the exact dissociation constant, we purifi ed the central domain of 
Srv2/CAP that does not contain any tryptophans and performed quantitative tryptophan 
fl uorescence assay with recombinant wild-type profi lin.  This assay revealed a Kd of 1,3 
μM for the interaction between profi lin and Srv/CAP. When we used a profi lin mutant 
lacking polyproline binding site (Pfy1-14)(Wolven et al., 2000) in the same assays, we 
did not detect any binding, which suggests that profi lin interacts with a polyproline 
region of Srv2/CAP (Fig. 6).
In order to reveal the profi lin binding site in Srv2/CAP, we carried out mutagenesis 
analysis on proline residues of both polyproline regions. By a series of supernatant 
depletion pull-down assays and tryptophan fluorescense assays of Srv2/CAP, we 
concluded that Srv2/CAP binds profi lin through its fi rst polyproline region. In order to 
ensure that mutations do not interfere with Srv2/CAP’s actin binding, we carried out 
actin binding assays and measured the interaction parameters by fl uorescence change of 
NBD-labeled ADP-G-actin. By replacing three prolines with alanines in this region, the 
affi nity of Srv2/CAP to actin was retained similar to the wild type protein. We also tested 
whether profi lin interferes with Srv2/CAP’s actin binding or actin excludes profi lin from 
Srv2/CAP. Both assays suggested that these two proteins are able to interact with Srv2/
CAP simultaneously without competition. 
These biochemical assays demonstrate that two highly abundant actin binding 
proteins, Srv2/CAP and profi lin, interact directly. Previous biochemical studies show that 
a sequence consisting of ten prolines is optimal for profi lin binding (Perelroizen et al., 
1994). Yeast Srv2/CAP contains nine prolines in the fi rst (P1) and fi ve in the second (P2) 
proline-rich region. In previous fl uorescence spectroscopy studies, profi lin was shown 
to interact with a dissociation constant of 5 μM with a 15-residue long synthetic peptide 
that corresponds to the fi rst polyproline region (P1) of mammalian CAP (Lambrech et 
al., 1997). By tryptophan fl uorescence assay, we measured approximately four-fold 
higher affi nity for profi lin for the 120 residue long central fragment of yeast Srv2/CAP. 
This difference may result from the differences between mammalian and yeast proteins 
or more likely from the fact that also the adjacent residues around the proline-rich region 
of Srv2/CAP are important for binding. 
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In yeast Srv2/CAP, the profi lin binding is located in the fi rst proline-rich region 
(P1), whereas mutations in P2 had no effect (Fig. 6). The mammalian P1 region is 
highly conserved with yeast protein but contains higher number of prolines. (e.g. P1 of 
mouse CAP1 contains 14 prolines). Yeast and mammalian profi lins are highly similar 
and the binding surface in Srv2/CAP is conserved to mammalian CAP1. This suggests 
interaction also between mammalian CAP and profi lin. Similar series of assays could 
perhaps show if the interaction is conserved to mammals and lighten the comparable 
functions of yeast and mammalian Srv2/CAP proteins. 
The second polyproline stretch (P2) mediates binding to the SH3 domain of Abp1 
and regulates the localization of Srv2/CAP in yeast. In mammals, P2 region is poorly 
conserved and does not contain a consensus sequence for SH3-domain binding (Freeman 
et al., 1996). As a result, the role of the P2 region in mammalian CAP and the mechanism 
regulating the subcellular localization of this protein remains elusive.  
Our data show that Srv2/CAP can simultaneously bind both profi lin and ADP-G-
actin, thus suggesting a ternary complex formation. This is supported by previous studies 
showing the ability of profi lin to bind polyproline and actin simultaneously (Mahoney et 
al., 1997). Together these data propose that ADP-actin fi rst binds to the high affi nity site 
in the C-terminal region of Srv2/CAP, while profi lin binds to P1 region of the Srv2/CAP 
and establishes a close contact with the ADP-actin monomer. At the following stage, 
nucleotide exchange of actin is stimulated by profi lin, Srv2/CAP or by both. Because 
Srv2/CAP has low and profi lin high affi nity to ATP-G-actin, profi lin receives ATP-actin 
monomer from Srv2/CAP and subsequently dissociates from Srv2/CAP (Witke et al., 
2001, Mattila et al., 2004). After this, the profi lin-ATP-G-actin complex can be used for 
dynamic growth of actin fi laments promoted by for example formins (Vavylonis et al., 
2006). We propose that the Srv2/CAP, which binds both profi lin and ADP-actin, could 
function as a “loading station” for profi lin-ATP-actin that will be subsequently used 
for spatially and temporally controlled actin polymerization. In yeast cells, Srv2/CAP 
maintains a suffi cient ATP-actin monomer pool ready for rapid actin polymerization. 
Thus, the loss of Srv2/CAP would result in a diminished amount of ATP-G-actin and 
subsequent defects in actin-based cellular functions. 
4.2. In vivo role of the Srv2/CAP-profi lin interaction
We next examined whether profilin binds Srv2/CAP also in vivo and whether this 
interaction has any physiological role in yeast cells. We generated a yeast strain srv2-201 
harboring mutations that change 3 prolines to alanines at the P1 site of Srv2/CAP. These 
mutations effi ciently deplete profi lin binding in biochemical assays without interfering 
with interaction with actin. Co-immunoprecipitation analysis demonstrated that direct 
interaction between Srv2/CAP and wild-type profi lin does occur in yeast cells. Profi lin 
was not detected in immunoprecipitations of srv2-201 cell extracts, suggesting that P1 
region of Srv2/CAP is essential for profi lin interaction also in vivo.
In order to investigate the signifi cance of Srv2/CAP’s profi lin binding in vivo, we 
carried out cell biological analysis of the srv2-201 yeast cells. Similarly to wild type 
cells, in srv2-201 cells, mutant Srv2/CAP localizes to patch-like structures, partially 
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overlapping with actin patches (Freeman et al., 1996). Thus, the P1 region is not 
important for the correct subcellular localization of Srv2/CAP. A deletion of Srv2/CAP 
from Saccharomyces cerevisiae (srv2Δ) shows reduced growth rates in all temperatures 
tested, depolarized actin patches and cables, and enlarged cell size (Gerst et al., 1991, 
Votjek et al., 1991). Importantly, srv2-201 yeast strain did not display obvious defects 
in growth or actin distribution. However, srv2-201 yeast strain showed statistically 
signifi cant enlargement in cell size suggesting that Srv2/CAP-profi lin interaction is more 
supportive than crucial in regulation of cell growth and morphology. Because of the high 
general importance of Srv2/CAP and profi lin in actin dynamics, the direct interaction 
would be assumed to have more severe phenotype. The test modes for yeast strain 
phenotypes in laboratory conditions are quite limited. It is thus possible that specifi c 
conditions (e.g. certain types of stress), not included in this study, exist and where Srv2/
CAP-profi lin interaction may become more crucial and srv2-201 strain, without a normal 
loading of ATP-actin-profi lin monomers, could fail to tolerate it. We also tested srv2-201 
mutant yeasts for possible genetic interactions with pfy1-4, cof1-19 and aip1Δ, each 
of which is synthetic lethal with srv2Δ. srv2-201 did not have any additional defects 
when crossed with cof1-19 and aip1Δ strains. However, srv2-201 partially suppressed 
the phenotype caused by pfy1-4, suggesting specifi c genetic interaction between these 
two genes. pfy1-4 mutant cells have greatly diminished actin cable staining, depolarized 
distribution of actin patches and inability to concentrate patches to the growing bud. 
In pfy1-4 srv2-201 yeasts patch polarization and enrichment to the bud was partially 
rescued, whereas restoration of cables was not detected.
Together, these data suggest that Srv2/CAP interacts with profi lin also in vivo. At 
least in yeast, profi lin plays an important role by promoting nucleotide exchange of ADP-
actin monomers (Wolwen et al., 2000, Lu and Pollard, 2001). As a result, ATP-actin 
or ATP-actin-profi lin complexes can be used for new rounds of actin polymerization. 
Reducing profi lin’s affi nity to ATP-actin in pfy1-4 cells results in decrease in generation 
of functional ATP-G-actin from ADP-G-actin (Wolven et al., 2000). We propose that in 
yeast cells profi lin interacts with P1 region of Srv2/CAP and receives the actin monomer 
from the high affi nity actin binding site of Srv2/CAP. Pfy1-4 has reduced affi nity for 
actin, which may result in Pfy1-4 getting stuck to the Srv2/CAP. In srv2-201 strain, 
the profi lin sequestering activity of Srv2/CAP is depleted and Pfy1-4 remains free to 
perform its role in actin dynamics more effectively, resulting in a partial rescue of the 
phenotype. An alternative explanation for the genetic interaction with pfy1-4 and srv2-
201 is that interaction with mutant profi lin Pfy1-4 may hinder the nucleotide exchange 
function of Srv2/CAP. With profi lin-free Srv2-201 protein, the nucleotide exchange 
of actin may be more effi cient and that would rescue the patch phenotype, whereas 
restoration of formin-nucleated cables would fail due to the reduced amount of profi lin-
actin complexes. To test this hypothesis, one could set up a more sensitive nucleotide 
exchange assay. For this assay the nucleotide exchange function of Srv2/CAP should be 
specifi cally depleted by mutagenesis from both wild-type and Srv2-201. Then one could 
test whether the mutant profi lin Pfy1-4 changes nucleotide more effectively when bound 





5. Characterization of Srv2/CAP-cofi lin interaction (II)
  
The rate-limiting step of actin turnover is the dissociation of ADP-actin monomers from 
fi lament pointed ends (Pollard 1986). ADF/cofi lins (referred to as cofi lin henceforth) 
play an essential role in accelerating monomer dissociation from fi laments and releasing 
actin monomers for new rounds of polymerization (Carlier, 1997). After dissociation 
from fi laments, cofi lin remains bound to ADP-actin, and inhibits its nucleotide exchange. 
Srv2/CAPs have been proposed to function as a high molecular weight complex that 
would play an important role in displacing cofi lin from ADP-actin to sustain effi cient 
turnover (Moriyama and Yahara, 2002, Balcer et al., 2003).
5.1. Generating the Srv2/CAP-actin complex
We purifi ed a full-length recombinant Srv2/CAP from E.coli cells and reconstituted a 
Srv2/CAP-actin complex. This approximately 600 kD complex consists of six Srv2/CAP 
and six ADP-actin molecules. The full-length Srv2/CAP and the N-terminal half of the 
protein can form a hexamer also in the absence of actin. C-terminal half and the full-
length protein lacking only the N-terminal coiled-coil structure form dimers. 
The reconstituted Srv2/CAP-actin complex co-migrated in gel fi ltration assay and 
had same hydrodynamic properties than the native yeast Srv2/CAP-actin complex. This 
complex also promoted nucleotide exchange of cofi lin-bound actin in a similar manner 
to the native Srv2/CAP complex (Balcer et al., 2003). We also revealed that full-length 
Srv2/CAP displays nearly identical affi nities to ADP- and ATP-G-actin and effects on 
nucleotide exchange rates as previously shown for the C-terminal half of yeast Srv2/
CAP (Balcer et al., 2003, Mattila et al., 2004). In Pi-release assay, in which the overall 
effects of Srv2/CAP to the cofi lin-mediated actin turnover are detected, full-length Srv2/
CAP protein and its separate domains combined together induced strong increase in 
actin turnover. However, separate Srv2/CAP domains alone or mutant protein lacking 
the coiled-coil domain displayed severe defects in promoting actin turnover. 
In vivo, Srv2/CAP is suggested to form a high molecular weight complex (Balcer 
et al., 2003). Already early co-immunoprecipitation studies showed that oligomerization 
or at least dimerization of Srv2/CAP occurs also in vivo (Hubberstey et al., 1996). 
Studies on full length Srv2/CAP have been diffi cult due to problems arising from auto-
proteolysis (Ksiazek et al., 2003) and aggregation of recombinant CAP (Yosof et al., 
2006). Absence of the physiological components of the complex may also result in the 
unstable nature of the purifi ed recombinant proteins. For these reasons, most studies 
with CAP have been carried out with purifi ed fragments of this protein. Both C- and N-
terminal (without the coiled-coil region) domains crystallize as homodimers (Dodatko 
et al., 2004, Ksiazek et al., 2003, Mavoungou et al., 2004). In our assays, C-terminal 
domain was a dimer, whereas full-length proteins form a hexamer. These data suggest 
that in an intact hexameric complex, N- and C-terminal domains interact with only one 
other domain, thus forming a homodimer, whereas hexamerization occurs through the 
coiled coil region (Fig. 6). Interestingly, in the structure of N-terminal CAP (Fig 6.) the 
C-and N- terminal ends of the amino acid chain point to the same direction, which is 
controversial to the model we suggest. However, both coiled-coil and the central domain 
missing from the structure are so long that they could easily reach to the orientation 
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proposed in our model. In future, it would be very informative to solve the high 
resolution structure of the full-length CAP and the intact hexamer.
Our analysis also suggests that hexamerization of Srv2/CAP alters the biochemical 
properties of this protein. The C-terminal half of Srv2/CAP has similar nucleotide-
exchange and ADP-actin binding properties as the full-length protein, regardless of the 
different oligomerization state. However, in Pi release assay, only a full-length protein 
or N- and C-terminal domain combined together promoted a concentration-dependent 
enhancement of cofi lin-induced actin turnover. The separate domains alone or the full-
length protein lacking coiled-coil domain required for hexamerization displayed severe 
defects in actin dynamics. Pi-release assay does not only measure a separate protein 
function such as actin-binding or nucleotide-exchange assays, but refl ects the function of 
this protein in more comprehensive way. Together these data suggest that both functional 
C- and N-terminal domains of Srv2/CAP as well as its hexamerization are needed for 
optimal enhancement of cofi lin-induced actin turnover in vitro.
5.2. Yeast Srv2/CAP interacts with cofi lin in vitro
Earlier studies suggested that mammalian CAP interacts with cofi lin-actin complex 
(Moriyma and Yahara 2002), but the mechanism and cellular role of this interaction were 
not known. By supernatant depletion pull-down assay, we demonstrated that yeast cofi lin 
binds to full-length yeast Srv2/CAP, but only in the presence of ADP-actin monomers. 
In order to rule out the possibility of this interaction occurring through actin, we also 
repeated the experiment with the N-terminal half of the Srv2/CAP, which does not bind 
actin. Also this domain effi ciently interacted with cofi lin-actin. The N-terminal region of 
Srv2/CAP harbors a 14-3-3-like domain that in other proteins is capable to bind cofi lin 
(Birkenfi eld et al., 2003). In order to map the cofi lin binding site of Srv2/CAP, we 
introduced several mutations to the 14-3-3-like domain of yeast Srv2/CAP. Two of the 
mutants, Srv2-90 and Srv2-91, showed clear defect in an interaction with cofi lin-actin 
complex. This data clearly points the interaction site to the conserved surface residues 
depleted from mutants Srv2-90 and Srv2-91 (Fig. 6). Furthermore, in a Pi-release assay 
the mutants Srv2-90 and Srv2-91 did not enhance cofi lin-mediated actin turnover.
Next, we wanted to map the Srv2/CAP binding site of cofi lin. Previous systematic 
mutagenesis of yeast cofi lin identifi ed two mutants, Cof1-5 and Cof1-9, which display 
severe phenotypes in yeast, but do not show defects in actin interactions in vitro 
(Lappalainen et al., 1997). Therefore, we tested whether these two mutants display 
defects in Srv2/CAP binding. In pull-down assays Cof1-5 and Cof1-9 failed to interact 
with Srv2/CAP even in the presence of ADP-actin. We also learned that addition of the 
N-terminal domain of Srv2/CAP increased affi nity of cofi lin to ADP-actin, indicating 
formation of a ternary complex. Importantly, Cof1-5 and Cof1-9 bound to ADP-G-actin 
with normal affi nity even in the presence of excess of N-Srv2. These data provide further 
support for the model that the Srv2/CAP binding site lies in the surface residues mutated 
in Cof1-5 and Cof1-9 (Fig. 6).   
In early studies, Srv2/CAP was proposed to sequester actin monomers and suppress 
actin polymerization (Freeman et al., 1995, Gieselmann and Mann 1992, Hubberstey 
et al., 1996, Zelicof et al., 1996). However, more recent studies suggested that Srv2/
CAP instead plays an important role in accelerating cofi lin mediated actin turnover 
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(Balcer et al., 2003, III). Identifi cation of a direct interaction between yeast Srv2/CAP 
and cofi lin-actin provides further support to this. Importantly, without ADP-actin, Srv2/
CAP is able to bind cofi lin only marginally. This confi rms that only actin-bound cofi lin 
is delivered to Srv2/CAP and enhances recycling of cofi lin for new depolymerization 
events, while the ADP-G-actin is transferred to high affi nity C-terminal domain of Srv2/
CAP (Mattila et al., 2004). The mutants that were defective in cofi lin-binding also failed 
to accelerate cofi lin-induced actin turnover in the context of the full-length Srv2/CAP, 
suggesting that direct interaction between Srv2/CAP and cofi lin is required to effi ciently 
deliver ADP-actin monomers from cofi lin to the high affi nity actin binding site at the C-
terminal region of Srv2/CAP. This function could provide an effective way of regulation. 
If cells could, for example, inhibit the interaction between Srv2/CAP and cofi lin by 
phosphorylation, this could lead to a reduced depolymerization rates of actin. But this 
needs further studies with signal cascades regulating the function of Srv2/CAP.
The important role of Srv2/CAP-cofi lin interaction is further supported by strong 
growth phenotypes of cof1-5 and cof1-9 mutants (Lappalainen et al., 1997), which in 
our assays failed to interact with Srv/CAP in vitro. In a three-dimensional structure, 
the residues mutated in Cof1-5 and Cof1-9 are located next to the G-actin binding site 
of cofi lin, but do not overlap with it. In the three-dimensional model of the cofi lin-
actin complex (Wriggers et al., 1998), the residues important for Srv2/CAP interaction 
are optimally located to mediate binding to other proteins. These residues also do not 
overlap with the F-actin binding site of cofi lin, but the possible interaction of Srv2/CAP 
with the cofi lin-F-actin complex needs to be studied. To test this, one could set up a high 
speed co-sedimentation assay and see if the Srv2/CAP also binds cofi lin/ADP-F-actin. 
This should also be tested with mammalian CAP. The localization signal of mammalian 
CAP is currently unknown. Binding to F-actin bound cofi lin would perhaps localize 
CAP to sites of rapid actin turnover similarly to yeast Abp1 mediated localization. This 
needs further investigation.
5.3. Interaction of Srv2/CAP with cofi lin in vivo
In a clear correlation to in vitro studies, mutant strains srv2-90 and srv2-91 showed 
similar phenotype to srv2Δ, whereas srv2-94, which did not affect cofi lin binding in 
vitro, was indistinguishable from wild type cells. As an independent assay SRV2, srv2-
90, srv2-91 and srv2-94 were crossed to pfy1-4 and cof1-19, both synthetically lethal 
with srv2Δ (Wolven et al. 2000, Balcer et al., 2003). srv2-90 and srv2-91 showed strong 
synthetic phenotypes with both alleles, interaction with pfy1-4 being more severe. srv2-
94 showed unaltered phenotype in these genetic backgrounds, again suggesting srv2-94 
strain to be comparable to wild-type strain.
Deletion of SRV2 gene from Saccharomyces cerevisiae results in a severe phenotype 
with enlarged cell size, loss of visualized actin cables and unpolarized patch distribution 
(Fedor-Chaiken et al., 1990, Field et al., 1990). This phenotype reveals the importance 
of Srv2/CAP in yeast actin dynamics. By mutating the previously mentioned cofi lin-actin 
binding site from Srv2/CAP (srv2-90 and srv2-91) the phenotype is almost as severe. 
Depletion of the Srv2/CAP binding site from cofi lin (cof1-5 and cof1-9) also results in 
obvious actin phenotype (Lappalainen and Drubin, 1997 and Lappalainen et al., 1997). 
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Together, these data suggest that the recycling of cofi lin is crucial for the function of the 
Srv2/CAP in yeast cells. In the future, it remains to be studied whether this interaction 
is also important in CAP proteins of other organisms. In cultured mammalian cells 
this could be studied by depleting the endogenous CAP by RNAi and replacing it by 
transfecting specifi cally mutated CAP constructs to the cells. 
Figure 6.  Structures of profi lin, cofi lin and CAP. Interaction sites are indicated with colours, 
green: G-actin binding, yellow: F-actin binding, red: Srv2/CAP binding, purple: cofi lin binding 
and blue: profi lin binding. Dashed lines show currently unsolved structural domains of Srv2/CAP.
The coordinates for yeast cofi lin, profi lin, C-terminal Srv2/CAP and Dictyostelium discoideum 
N-terminal CAP were obtained from Wriggers et al., 1998, Eads et al., 1998, Mavoungou et al., 
2004 and Dodatko et al., 2004.
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6. Role of the CAP in mammalian cells (III)
  
CAP proteins have been characterized in all eukaryotic organisms studied. Yeasts and 
other single cell organisms have only one isoform of CAP, whereas all mammals studied 
so far have two isoforms (Yu et al., 1994, Swiston et al. 1995). Possible differences 
in expression patterns of CAP isoforms in mammalian tissues have been studied only 
by RT-PCR method (Swiston et al. 1995). Also subcellular localization of CAP in 
mammalian cells and its contribution to actin dynamics have remained elusive. 
6.1. Identifi cation of two mouse CAP isoforms
It has been reported that at least humans and rats have two different isoforms of CAP 
(Yu et al., 1994, Swiston et al., 1995). We wanted to identify the other CAP isoform 
from mice and to further investigate possible differences in their expression patterns. By 
performing sequence database searches we found mouse CAP2, which is approximately 
60% identical to the previously identifi ed mouse CAP1 (Votjek and Cooper, 1993). We 
carried out northern blot and in situ-hybridization assays to elucidate the expression 
of these two isoforms in different tissues. CAP1 mRNA was expressed widely during 
all stages of embryogenesis and in all adult tissues except in skeletal muscles. The in 
situ-hybridizations also provided evidence that CAP1 mRNA is the major isoform in 
most tissues. CAP2 mRNA signal was weak in samples trough embryogenesis, but was 
strongly expressed in adult heart, brain and skeletal muscles, being also the only isoform 
in adult striated skeletal muscles. This was further supported by in situ-hybridization 
analysis showing that CAP2 expression is restricted to developing myotubes and to adult 
skeletal muscles. In adult mice, CAP2 was also expressed in certain areas of the brain 
distinct from those in which CAP1 is expressed. We also generated specifi c, non-cross 
reacting antibodies against CAP1 and CAP2, and learned that CAP2 was not expressed 
in any of the non-muscle cell lines tested. On the other hand, CAP1 was highly abundant, 
being expressed at levels equal to those of cofi lin-1 in NIH3T3- and B16F1-cells. In 
these cells, CAP1 localized diffusely to cytoplasm, but also clearly concentrated to 
actin-rich membrane-ruffl es and showed a uniform staining in lamellipodia of migrating 
fi broblasts. In both NIH3T3 and B16F1 cells, CAP1 also colocalized with cofi lin-1 
antibody staining.
Together these studies revealed that at least one CAP isoform is expressed in 
all tissues during embryogenesis and in adult mice, suggesting that CAP is a central 
regulator of actin dynamics in all cell-types and stages of development. Interestingly, 
CAP2 is expressed specifi cally in striated muscles. In muscle cells, majority of actin is 
organized with motor protein myosin into highly stabile structures called sarcomeres, 
and the fraction of actin maintaining other cellular functions is much smaller than in 
non-muscle cells (Eddinger and Meer, 2007). We propose, that in order to maintain the 
actin dynamics in this highly specialized cell-type, muscle-specifi c CAP isoform has 
evolved. Same phenomenon has also been observed with other actin binding proteins 
such as ADF/cofi lin, twinfi lin and capping protein (Ono et al., 1994, Vartiainen et al., 
2003, Schafer et al., 1994,). Whereas the muscle-specifi c ADF/cofi lin isoform, cofi lin-2, 
is known to promote actin fi lament turnover less effi ciently than non-muscle isoforms 
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(Vartiainen et al. 2002), the biochemical differences of CAP isoforms have not been 
examined. All functional domains identifi ed from Srv2/CAP (I, II, Mattila et al., 2004) 
appear to be conserved in CAP1 and CAP2, suggesting at least similar functions, 
whereas the dynamics or regulatory steps can be different between these isoforms. A 
recent study demonstrated that CAP2 has a functional actin binding site like CAP1, and 
proposed that CAP2 is localized in the nuclei of undifferentiated myoblasts and to M-
line in mature myotubes (Peche et al., 2007). CAP2 was also reported to be upregulated 
in hepatocellular carsinoma in humans, but the cell biology behind this fi nding remains 
elusive (Shibata et al., 2006).
In non-muscle cells, CAP1 localizes to cell periphery at the sites of rapid actin 
turnover. Similar localization to cortical cytoskeleton was previously reported for 
Dictyostelium CAP (Noegel et al., 1999). According to previous reports, mammalian 
CAP1 localizes to the sites of rapid actin turnover (Moriyama and Yahara, 2002) and 
to stress fi bers (Freeman and Field, 2000). However, we only detected a very faint 
localization of CAP1 to stress fi bers in a fraction of NIH3T3 cells. In yeast, Srv2/CAP 
localizes partially to actin patches, which are sites of rapid actin dynamics similar to 
lamellipodia in mammalian cells (Freeman et al., 1996). In mammalian non-muscle cell, 
the uniform lamellipodial staining observed here for CAP1 is common for many proteins 
involved in rapid remodeling of actin structures, such as Arp2/3 and twinfi lin (Svitkina 
and Borisy, 1999, Vartiainen et al., 2000). Unlike cofi lin-1 (Yonezawa et al., 1987), 
CAP1 did not display localization to nucleus. However, clear colocalization between 
CAP1 and cofi lin-1 in lamellipodia in all cell-types tested suggest a functional link 
between these proteins also in mammalian cells. 
6.2. The role of CAP1 in mammalian non-muscle cells
We examined the role of CAP1 in B16F1 and NIH3T3 cells by depleting it using RNAi-
method (Elbashir et al. 2001). The cells were transfected with fl uorescein-labelled 
RNAi-oligonucleotides to distinguish RNAi transfected cells from non-transfected 
ones. Immunofluorescence analysis showed that the CAP1 RNAi transfected cells 
did not contain detectable levels of CAP1. The knock-down cells exhibited slightly 
enlarged and depolarized morphology and contained abnormal accumulation of F-actin 
structures. In order to further investigate the effects of CAP1 knock-down, we conducted 
an analysis on cell migration, endocytosis and actin turnover. CAP1 knock-down cells 
were generally unable to migrate directionally. Lamellipodial ruffl es were motile, but 
the migration speed was decreased to half as compared to wild-type. Also receptor-
mediated endocytosis of transferrin was decreased to 40% in knock-down cells. Uptaken 
transferrin was also diffusely distributed around the cell, in comparison to perinuclear 
localization typical to wild-type cells. 
In order to study the actin turnover rates in CAP1 knock-down cells, we used FRAP 
(Yoon et al., 2002). After bleaching the stress-fi bers in GFP-actin expressing cells, the 
recovery was monitored by live cell imaging. Recovery rates were clearly decreased in 
CAP1 depleted cells suggesting diminished actin turnover rates. To further elucidate the 
reason for reduced actin turnover, we tested the actin depolymerization rates in wild-type 
and CAP knockdown cells by Latrurunculin-A based assay (Lappalainen and Drubin, 
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1997). Latrunculin-A sequesters monomers dissociated from fi laments and prevents their 
addition to growing ends (Coue et al., 1987). After the Latrunculin-A treatment, actin 
fi laments were rapidly lost from wild-type cells, whereas in the CAP1 knock-down cells, 
F-actin structures disappeared more slowly. These data suggest that CAP1 promotes 
actin fi lament depolymerization in mammalian cells. Interestingly, after CAP1 knock-
down the major ADF/cofi lin isoform in these cells, cofi lin-1, was lost from its normal 
localization and aggregated to cytoplasm together with G-actin. 
Similar actin phenotypes with abnormal F-actin structures as revealed for CAP1 
knock-down cells have also been observed in Drosophila and Dictyostelium CAP 
mutants (Noegel et al., 1999, Baum et al., 2000, Benlali et al., 2000). CAP1 knock-
down cells had also a defect in receptor-mediated endocytosis. Vesicle traffi cking is 
known to be dependent on actin organization in mammalian cells (Fujimoto et al., 
2000), and Srv2/CAP is linked to vesicle traffi cking in yeast through synthetic lethality 
with the endocytic protein Sla2 (Lila and Drubin 1997). In theory, thick disorganized 
actin fi bers fi lling the cytoplasm of the CAP1 knock-down cells may have a physical 
infl uence in endocytosis without a direct link between CAP1 and any compartment of 
endocytic pathway. Nevertheless, recent fi ndings have linked Dictyostelium discoideum 
CAP directly to the dynamics of endo-lysosomal system (Sultana et al., 2005).
Interestingly, the actin phenotype of CAP1 knock-down cells clearly resembles 
to the ones reported for ADF/cofi lin knock-down in the same cell lines (Hotulainen 
et al., 2005). Similar phenotype was also detected from cells in which ADF/cofi lins 
were phosphorylated by over-expression of LIM-kinase. Phosphorylation effectively 
inactivates ADF/cofi lin leading to an accumulation of actin fi laments in the cells (Arber 
et al., 1998, Yonezava et al., 1991). In CAP1 knock-down cells, cofi lin-1 aggregates with 
actin to abnormal cytoplasmic structures and thus loses its normal activity. Our recent 
fi ndings with yeast cofi lin and Srv2/CAP proteins indicate that Srv2/CAP releases cofi lin 
from newly depolymerized ADP-actin (II). The fact that protein domains with relevance 
to this function are highly conserved in all Srv2/CAP proteins suggest that this function 
is probably also conserved in both mammalian CAPs (Moriyama and Yahara, 2002). 
CAP1 and CAP2 are highly similar proteins. CAP2 may have a similar role in recycling 
muscle specifi c ADF/cofi lin isoform, cofi lin-2, in muscle cells. Mutations in cofi lin-2 
gene in humans are known to cause a nemaline myopathy. Reduced depolymerization 
rate of actin fi laments by cofi lin-2 mutant causes accumulation of rod-like actin-rich 
structures called “nemaline bodies” to the muscles of the patients (Pankaj et al., 2007). 
Loss of CAP2 could also reduce the depolymerization rates of cofi lin-2 and cause 
similar, but probably milder, defects, regarding to the phenotypes detected in cofi lin-1 
and CAP1 defi cient cells.  
Thus, we propose that in cells lacking functional CAP protein, cofi lin accumulates 
with ADP-G-actin, which results in similar phenotype as seen in cells lacking ADF/
cofi lin. When functional CAP1 is present, cofi lin-1 is effectively recycled to new rounds 
of depolymerization and ADP-actin monomers are funneled to profi lin and subsequently 
to growing actin fi lament ends. These functions increase the overall actin treadmilling 




Figure 7. Model: The mechanism of CAP-function in actin turnover. 
1. Cofi lin binds to the ADP-actin in the fi lament. Cofi lin twists the fi lament and promotes 
breakage and subunit dissociation. Cofi lin remains bound to the ADP-actin monomer and 
strongly inhibits nucleotide exchange.
2. Cofi lin-ADP-G-actin complex binds to the N-terminal 14-3-3 like domain of Srv2/CAP and 
forms a three-protein complex. In budding yeast, Srv2/CAP localizes to F-actin structures via 
interaction with Abp1, a protein binding fi lamentous actin. In mammalian cells, this interaction 
is not conserved, and currently unknown interaction localizes CAP1 to the sites of rapid actin 
turnover. For clarity reasons, Abp1 is excluded from the picture.   
3. ADP-G-actin is transferred from cofi lin to the high-affi nity binding site of the C-terminal Srv2/
CAP. Another alternative is that the nucleotide of actin is exchanged when the monomer is still 
bound to cofi lin. In any case, the correct three-dimensional structure and close proximity of 
N- and C-terminal domains of either same or adjacent Srv2/CAP subunits in the hexamer 
is needed for the function. Due to the low affi nity of N-terminal domain of Srv2/CAP to 
actin-free cofi lin, it probably dissociates rapidly from Srv2/CAP. This releases cofi lin for new 
rounds of actin fi lament depolymerization. In yeast cells deletion of the interaction site needed 
for cofi lin-actin-Srv2/CAP complex either from cofi lin (cof1-5, cof1-9) or Srv2/CAP (srv2-90, 
srv2-91) results in severe actin disorganization similar to deletion of Srv2/CAP. In mammalian 
non-muscle cells, from which CAP1, the only isoform expressed, is depleted, cofi lin is not 
effi ciently released from ADP-G-actin and it forms abnormal aggregates with actin at the 
cytoplasm. This results in reduced actin fi lament turnover rates and accumulation on F-actin 
structures inside the cell. 
4. Profi lin binds to the fi rst polyproline-rich region of Srv2/CAP while the ADP-actin monomer is 
bound to the C-terminal actin-binding site. Both profi lin and Srv2/CAP can promote nucleotide 
exchange of G-actin, but this possibly synergistic function needs further investigation. 
Nevertheless, actin is converted effi ciently into ATP-G-actin form. Because Srv2/CAP has 
much lower affi nity to ATP- than to ADP-actin monomers and conversely profi lin binds ATP-
G-actin with high affi nity, the monomer is transferred to profi lin. If the interaction between 
these two proteins is excluded (srv2-201), the actin monomer can still be transferred to profi lin 
or the nucleotide of ADP-actin are exchanged by Srv2/CAP, providing adequate amount of 
ATP-actin monomers in cells. Thus, under normal growth conditions, a loss of this function 
causes only a mild enlargement of cell size.
5. Profi lin-ATP-actin complex is released from Srv2/CAP and it is now free to be added into 
growing barbed ends of the fi laments. 
7. Model: Role of Srv2/CAP in actin turnover 
Based on present results, we suggest a model for the function of Srv2/CAP in cells. A 
schematic picture of how Srv2/CAP contributes to remodeling of the actin cytoskeleton 
by accelerating turnover rate or in more detail, funnels actin monomers from pointed 
end depolymerizing factor cofi lin to profi lin and further to barbed end growth, is shown 
in Figure 7. For clarity only one molecule of Srv2/CAP1 is drawn, although our studies 




This study demonstrates that CAP proteins play an important role in accelerating actin 
fi lament turnover in both yeast and mammalian cells. We propose that CAP binds newly 
depolymerized cofi lin-ADP-G-actin complexes and assists the release of cofi lin to further 
perform its function. CAP also promotes nucleotide exchange of actin and thus charges 
profi lin-ATP-G-actin complexes for subsequent rounds of fi lament polymerization. 
However, several steps of this model need further investigation to reveal the exact 
mechanism by which CAP promotes actin dynamics.
An interesting result from these studies is the fact that hexamerization is required for 
optimal function of CAP proteins. In future, it will be important to obtain structural data 
of the complex, in order to understand why hexamerization is important for the function 
of CAP. CAP is also likely to harbor several binding sites for currently unknown ligands. 
These could be, for example, members of Ras-signaling pathway, as suggested in studies 
with yeast. In order to examine this, one could carry out pull-down assays to identify 
CAP’s interaction partners from the cell lysate and identify the co-purifying partners 
by mass-spectrometry. Identifi cation of these binding partners that could, for example, 
regulate the localization of mammalian CAPs would bring important new information 
about the protein. It is also important to note that there are some differences in the actin 
dynamics between yeast and mammalian systems. Although the core functions of the 
CAP seem to be well conserved, the possible differences between mammalian and yeast 
CAPs remain to be studied. Also the specifi c functions of the CAP2, developed to fulfi ll 
the needs of muscle cells, will be important to examine. These assays require purifi cation 
of similar mammalian recombinant proteins, both CAP1 and CAP2, and setup a similar 
series of experiments as carried out in this study for yeast Srv2/CAP. 
Very little is known of the pathways regulating the activity of Srv2/CAP proteins. As 
in the cases of many other actin binding proteins, phosphorylaton and interactions with 
PIP2 may regulate CAPs. Thus, the possible phosphorylation status and phosphorylation 
sites of CAPs should be identifi ed. Furthermore, the possible PIP2 binding of CAPs 
should be confi rmed by fl uorometric methods and vesicle pull-down assays. Also studies 
of currently unknown post-translational modifi cations of Srv2/CAP proteins should 
be tested. Adding these regulatory mechanisms to the model would lead us closer in 




This study was carried out at the Institute of Biotechnology, University of Helsinki, 
with fi nancial support from Helsinki Graduate School in Biotechnology and Molecular 
Biology. 
I wish to express my greatest gratitude to my supervisor Professor Pekka 
Lappalainen, for the opportunity to work in the inspiring atmosphere of his lab. His 
endless interest and enthusiasm towards the projects is admirable. I also want to thank 
Pekka as head of the Helsinki Graduate School in Biotechnology and Molecular Biology 
and other school staff for providing a supportive and well-organized environment for my 
PhD studies.
I wish to thank Professor Mart Saarma, the director of the Institute of Biotechnology 
for excellent research and core facilities. I also want to thank Professor Tapio Palva, 
the head of the Division of genetics, for his positive and easygoing attitude towards 
my studies. I am deeply grateful for Docent Marko Kallio and Docent Jussi Jäntti for 
the critical reading of my thesis and giving constructive suggestions for improving it. I 
also want to thank Jussi and Docent Johan Peränen for support and encouragement in 
follow up-group meetings during the years.  I also want to thank Pekka’s daily 2 o’clock 
meeting members for the ideas, which Pekka at 3 o’clock introduced to me as his own.   
I wish to thank all my co-authors Docent Marjo Salminen and Tanja Matilainen for 
their experience in in situ-hybridizations and Doctor Bruce Goode and Omar Quintero-
Monzon for long and unhurried, but fruitful collaborations with yeast in vivo-studies. 
The Lappalainen group was an excellent place to start the scientifi c career. Great 
group spirit and our “sweat and suffer”-days are unforgettable. A friend and support was 
always as near as the closest lab bench and our crazy Friday coffee-break conversations 
made the failed experiment feel much less devastating. Thank you all, Pekka, Pauli, 
Maria, Sandra, Ville, Pieta, Pirta, Perttu, Elisa, Juha, Keke, Miia, Aneta, Ansku, Maarit, 
Zhao, Sari and Anna-Liisa. Pieta is also thanked for teaching the basics when I fi rst came 
to lab and Maarit for taking care of all my unfi nished projects. Especially I want to thank 
Pirta for valuable friendship but also for the support and advice in cell biological and 
microscopic techniques.
Outside the lab, I have been lucky to fi nd so many great friends. Thank you all for 
being such a diverse group of people and personalities around me. That is a true richness. 
Especially I wish to thank Maija, who I can love and hate as a real sister.
With all my heart I thank my parents, Arno and Sirpa, who always supported me to 
be whatever I wanted. I also wish to thank my present three families, Emppu’s, Äiti’s 
and Salminen’s for providing me a precious safe places where I can always go and eat 
from their fridges. 
Finally, I would like to thank my dogs, Jassu and her successor Jekku, who took me 
out every day and kept my tight schedule reasonable. The biggest hugs and kisses go to 
my dear Pauli who shares the daily routines, unforgettable holidays and crazy dreams 





Adams, A. E. and Pringle, J. R. 1984. Relationship of actin and tubulin distribution to bud growth 
in wild-type and morphogenetic-mutant Saccharomyces cerevisiae. J. Cell Biol. 98:934-945.
Aitken, A. 2006. 14-3-3 proteins: A historic overview. Review. Seminars in Cancer Biology. 
16:162-172.
Arber, S., Barbayannis, F. A., Hanser, H., Schneider, C., Stanyon, C. A., Bernard, O. and Caroni, 
P. 1998. Regulation of actin dynamics through phosphorylation of cofi lin by LIM-kinase. Nature. 
393:805 – 809.
Balcer, H. I., Goodman, A. L., Rodal, A. A., Smith, E., Kugler, J., Heuser, J. E. and Goode, B. L. 
2003. Coordinated regulation of actin fi lament turnover by a high-molecular-weight Srv2/CAP 
complex, cofi lin, profi lin, and Aip1. Curr. Biol. 13:2159-2169.
Bamburg, J.R., Harris, H.E. and Weeds, A.G. 1980. Partial purifi cation and characterization of an 
actin depolymerizing factor factor from brain. FEBS Letters. 121(1):178-182.
Bamburg, J.R. 1999. Proteins of the ADF/cofi lin family: Essential Regulators of Actin Dynamics. 
Review.  Annu. Rev. Cell Dev. Biol. 15:185-230.
Bamburg, J.R. and Wiggan, O.P. 2002. ADF/Cofi lin and actin dynamics in disease. Review. 
Trends in Cell Biol. 12:598-605
Barrero, R.A., Umeda, M., Yamamura, S. and Uchimiya, H. 2002. Arabidopsis CAP regulates the 
actin cytoskeleton necessary for plant cell elongation and division. The Plant Cell. 14:149-163.
Barrero, R.A., Umeda, M., Yamamura, S. and Uchimiya, H. 2003. Over-expression of Arabidopsis 
CAP causes decreased cell expansion leading to organ size reduction in transgenic tobacco plants. 
Annals of Botany. 91:599-603.
Barry, D.M., Millecamps, S., Julien, J.P. and Garcia, M.L. 2007. New movements in neurofi lament 
transport, turnover and disease. Review. Exp. Cell Res. 313(10):2110-20. 
Baum, B., Li, W. and Perrimon, N. 2000. A cyclase-associated protein regulates actin and cell 
polarity during Drosophila oogenesis and in yeast. Curr. Biol. 10:964-973.
Bear, J.E., Svitkina, T.M., Krause, M., Schafer, D.A., Loureiro, J.J., Strasser, G.A., Maly, I.V., 
Chaga, O.Y., Cooper, J.A., Borisy, G.G. and Gertler, F.B. 2002. Antagonism between Ena/VASP 
proteins and actin fi lament capping regulates fi broblast motility. Cell. 109:509-521.
Benlali, A., Draskovic, I., Hazelett, D. and Treisman, K. 2000. Act up controls actin 
polymerization to alter cell shape and restrict Hedgehog signaling in the Drosophila eye disc. 
Cell. 101:271-281.
Bhat, K.M. and Setaluri, V. 2007. Microtubule-associated proteins as targets in cancer 
chemotherapy. Review. Clin. Cancer Res. 15;13(10):2849-54. 
Bi, E., Maddox, P., Lew, D.J., Salmon, E.D., McMillan, J.N., Yeh, E. and Pringle, J.R. 1998. 
Involvement of an actomyosin contractile ring in Saccharomyces serevisiae cytokinesis. J. Cell 
Biol. 142:1301-1304. 
Birkenfi eld, J., Betz, H. and Roth, D. 2003. Identifi cation of cofi lin and LIM-domain-containing 
protein kinase 1 as a novel interaction partners of 14-3-3ζ. Biochem. J. 369:45-54.
Blanchoin, L., Pollard, T.D. and Hitchcock-DeGregori, S.E. 2001. Inhibition of the Arp2/3 




Bretscher, A. 1999. Regulation of cortical structure by ezrin-radixin-moesin protein family. Curr. 
Opin. Cell. Biol. 11:109-116.
Bretscher, A. 2003. Polarized growth and organelle segregation in yeast: the tracks, motors, and 
receptors. J. Cell Biol. 160:811-6.
Buss, F., Temm-Grove, C., Henning, S. and Jockusch, B.M. 1992. Distribution of profilin 
in fibroblasts correlates with the presence of highly dynamic actin filaments. Cell Motil. 
Cytoskeleton. 37(2):51-61.
Caviston, J.P. and Holzbaur, E.L. 2006. Microtubule motors at the intersection of traffi cking and 
transport. Review. Trends Cell Biol. 16(10):530-7.
Carlier, M.F., Laurent, V., Santolini, J., Melki, R., Didry, D., Xia, G.X., Hong, Y., Chua, N.H. 
and Pantaloni, D. 1997. Actin depolymerizing factor (ADF/cofi lin) enhances the rate of fi lament 
turnover: implication in actin-based motility. J. Cell Biol. 136:1307-1322.
Carlsson, L., Nyström, L. E., Sundkvist, I., Markey, F. and Lindberg, U. 1977. Actin 
polymerizability is infl uenced by profi lin, a low molecular weight protein in non-muscle cells. J. 
Mol. Biol. 115:465-83. 
Cedergren-Zeppezauer, E.S., Goonesekere, N.C., Rozycki, M.D., Myslik, J.C., Dauter, Z., 
Lindberg, U. and Schutt, C.E. 1994. Crystallization and structure determination of bovine profi lin 
at 2.0 Å resolution. J. Mol. Biol. 240(5):459-475.
Chaudhry, F., Guérin, C., von Witsch, M., Blanchoin, L. and Staiger, C. 2007. Identifi cation of 
Arabidopsis cyclase-associated protein 1 as the fi rst nucleotide exchange factor for plant actin. 
Mol. Biol.  Cell. 18:3002-3014.
Cheeseman, I.M. and Desai, A. 2008. Molecular architecture of the kinetochore-microtubule 
interface. Review. Mol. Cell Biol. 9:33-46.
Cooley, L., Verheyen, E. and Ayers, K. 1992. Chikadee encodes a profi lin required for intercellular 
cytoplasm transport during Drosophila oogenesis. Cell. 69(1):173-184.
Coue, M., Brenner, S.L., Spector, I., and Korn, E.D. 1987. Inhibition of actin polymerization by 
latrunculin A. FEBS Lett. 213:316-318.
Coulombe, P.A. and Omary, M.B. 2002. ‘Hard’ and ‘soft’ principles defi ning the structure, 
function and regulation of keratin intermediate fi laments. Curr. Opin. Cell Biol. 14(1):110-22.
Coulombe, P.A. and Wong, P. 2004. Cytoplasmic intermediate fi laments revealed as dynamic and 
multipurpose scaffolds. Nat. Cell Biol. 6:699-706
Deeks, M.J., Rodrigues, C., Dimmock, S., Ketelaar, T., Maciver, S.K., Malhó, R. and Hussey, P.J. 
2007. Arabodopsis CAP1 -a key regulator of actin organization and development. J. Cell. Sci. 
120:2609-2618.
Dodatko, T., Fedorov, A.A., Grynberg, M., Patskovsky, Y., Rozwarski, D.A., Jaroszewski, L., 
Aronoff-Spencer, E., Kondraskina, E., Irving, T., Godzik, A. and Almo, S.C. 2004. Crystal 
structure of the actin binding domain of the cyclase-associated protein. Biochemistry. 43:10628-
10641.
Dominguez, R. 2004. Actin-binding proteins- A unifying hypotesis. Trends biochem. Sci. 
29(11):572-578. 
Drees, B., Sundin, B., Brazeau, E., Caviston, J., Guang-Chaou, C., Wei, G., Korminski, K., Lau, 
M., Moskow, J., Tong, A., Sckenkman, L., McKenzie, A., Brennwald, P., Longtine, M., Bi, E., 
References
36
Chan, C., Novick, P., Boone, C., Pringle, J., Davis, T., Fields, S. and Drubin, D.G. 2001. A protein 
interaction map for cell polarity development. J. Cell Biol. 3:549-571.
Eads, J.C., Mahoney, N.M., Vorobiev, S., Bresnick, A.R., Wen, K.K., Rubenstein, P.A., Haarer, 
B.K. and Almo, S.C. 1998. Structure determination and characterization of Saccharomyces 
cerevisiae profi lin. Biochemistry. 11;37(32):11171-81.
Eddinger, T.J. and Meer, D.P. 2007. Myosin II isoforms in smooth muscle: heterogeneity and 
function. Review.  Am. J. Physiol. Cell Physiol. 293(2):C493-508. 
Edlund, M., Lotano, M.A. and Otey, C.A. 2001. Dynamics of alpha-actinin in focal adhesions 
and stress fi bers visualized with alpha-actinin-green fl uorescent protein.  Cell Motil. Cytoskeleton. 
48:190-200.
Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K. and Tuschl, T. 2001. Duplexes 
of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:494-
498. 
Evangelista, M., Pruyne, D., Amberg, D.C., Boone, C. and Bretscher, A. 2002. Formins direct 
Arp2/3-independent actin fi lament assembly to polarize cell growth in yeast. Nat. Cell Biol. 
4:260-269.
Fedor-Chaiken, M., Deschenes, R.J. and Broach, J.R. 1990. SRV2, a gene required for RAS 
activation of adenylate cyclase in yeast. Cell. 61:329-340.
Fedorov, A.A., Lappalainen, P., Fedorov, E.V., Drubin, D.G. and Almo, S.C. 1997. Structure 
determination of yeast cofi lin. Nat. Struct. Biol. 4(5):366-9. 
Field, J., Vojtek, A., Ballester, R., Bolger, G., Colicelli, J., Ferguson, K., Gerst, J., Kataoka, T., 
Michaeli, T., Powers, M., Riggs, L., Rodgers, L., Wieland, I., Wheland, B. and Wigler, M. 1990. 
Cloning and characterization of CAP, the S.cerevisiae gene encoding the 70 kd adenylyl-cyclase 
associated protein. Cell. 61:319-327.
Fuchs, E. and Weber, K. 1994. Intermediate fi laments: structure, dynamics, function, and disease. 
Review. Annu. Rev. Biochem. 63:345-82.  
Freeman, N. and Field, J. 2000. Mammalian homolog of the yeast cyclase-associated protein, 
Srv2/CAP, regulates actin fi lament assembly. Cell Motil. Cytoskeleton. 45:106-120.
Freeman, N.L., Chen, Z., Horenstein, J., Weber, A. and Field, J. 1995. An actin monomer binding 
activity localizes to the carboxyl-terminal half of the Saccharomyces cerevisiae cyclase-associated 
protein. J. Biol. Chem. 270:5680-5685.
Freeman, N.L., Lila, T., Mintzer, K., Chen, Z., Pahk, P., Ren, R., Drubin, D. and Field, J. 1996. A 
conserved proline-rich region of the Saccharomyces cerevisiae cyclase-associated protein binds 
SH3 domains and modulates cytoskeletal localization. Mol. Cell. Biol. 16(2):548-556.
Fujimoto, L.M., Roth, R., Heuser, J.E. and Schmid, S.L. 2000. Actin assembly plays a variable, 
but not obligatory role in receptor-mediated endocytosis in mammalian cells. Traffi c. 1:161-171. 
Gieselmann, R. and Mann, K. 1992. ASP-56, a new actin sequestering protein from the pig 
platelets with homology to CAP, an adenylate cyclase-associated protein from yeast. FEBS Lett. 
298:149-153.
Gimona, M., Djinovic-Carugo, K., Kranewitter, W.J. and Winder, S.J. 2002. Functional plasticity 
of CH domains. FEBS Lett. 513(1):98-106.
Godsel, L.M., Hobbs, R.P. and Green, K.J. 2008. Intermediate fi lament assembly: dynamics to 
disease. Trends Cell Biol. 18(1):28-37. 
References
37
Goldschmidt-Clermont, P.J., Furman, M.I., Wachsstock, D., Safer, D., Nachmias, V.T. and 
Pollard, T.D. 1992. The control of actin nucleotide exchange by thymosin beta 4 and profi lin. A 
potential regulatory mechanism for actin polymerization in cells. Mol. Biol. Cell. 3:1015-1024.
Goode, B.L., Rodal, A.A., Barnes, G. and Drubin, D.G. 2001. Activation of the Arp2/3 coplex by 
the actin fi lament binding protein Abp1p. J. Cell Biol. 153:627-634. 
Goode, B.L., and Eck, M.J. 2007. Mechanisms and function of formins in the control of actin 
assembly. Annu. Rev. Biochem. 76:593-627.
Gottwald, U., Brokamp, R., Karakesisoglou, I., Schleicher, M. and Noegel, A.A. 1996. 
Identifi cation of a cyclase-associated protein (CAP) homologue in Dictyostelium discoideum and 
characterization of its interaction with actin. Mol. Biol. Cell. 7: 261-72. 
Gourlay, C.W. and Ayscough, K. 2006. Actin-induced hyperactivation of the Ras-signaling 
pathway leads to apoptosis in Saccharomyces cerevisiae. Mol. Cell. Biol. 26(17):6487-6501.
Gunsalus, K.C., Bonaccorsi, S., Williams, E., Verni, F., Gatti, M. and Goldberg, M.L. 1995. 
Mutations in twinstar, a Drosophila gene encoding a cofi lin/ADF homologue, result in defects in 
centrosome migration and cytokinesis. J. Cell Biol. 131(5):1243-59. 
Gupton, S.L. and Gertler, F.B. 2007. Filopodia: the fi ngers that do the walking. Sci. STKE. 2007:
re5.
Gurniak, C.B., Perlas, E. and Witke, W. 2005. The actin depolymerizing factor cofi lin-1 is 
essential for neural tube morphogenesis and neural crest cell migration. Dev. Biol. 278(1):231-
241.
Haarer, B.K., Lillie, S.H., Adams, A.E., Magdolen, V., Bandlow, W. and Brown, S.S. 1990. 
Purifi cation of profi lin from Saccharomyces cerevisiae and analysis of profi lin-defi cient cells. J. 
Cell Biol. 110:105-14.
Haas, M. and Jost, E. 2003. Functional analysis of phosphorylation sites in human lamin A 
controlling lamin disassembly, nuclear transport and assembly. Eur. J. Cell Biol. 62:237-247.
Halpain, S. and Dehmelt, L. 2006. The MAP1 family of microtubule-associated proteins. Review. 
Genome Biol. 7(6):224.
Hatanaka, H., Ogura, K., Moriyama, K., Ichikawa, S., Yahara, I. and Inagaki, F. Tertiary structure 
of destrin and structural similarity between two actin-regulating protein families. Cell. (7):1047-
55. 
Haugwitz, M., Noegel, A.A., Rieger, D., Lottspeich, F. and Schleicher, M. 1991. Dictyostelium 
discoideum  contains two profi lin isoforms that differ in structure and function. J. Cell Sci. 
100:481-489. 
Hawkins, M., Pope, B., Maciver, S.K. and Weeds, A.G. 1993. Human actin depolymerizing factor 
mediates a pH-sensitive destruction of actin fi laments. Biochemistry. 32(38):9985-93. 
Herrmann, H., Hesse, M., Reichenzeller, M., Aebi, U. and Magin, T. 2003. Functional complexity 
of intermediate fi lament cytoskeletons: From structure to assembly to gene ablation. Int. Rev. 
Cytol. 223:83-175.
Herrmann, H. and Aebi, U. 2004. Intermediate filaments: molecular structure, assembly 




Hesse, M., Magin, T.M. and Weber, K. 2001. Genes for intermediate fi lament proteins and the 
draft sequence of the human genome: novel keratin genes and a surprisingly high number of 
pseudogenes related to keratin genes 8 and 18. J. Cell Sci. 114(Pt 14):2569-75. 
Higgs, H.N. 2005. Formin proteins: A domain based approach. Trends biochem. Sci. 30(6):342-
353. 
Hotulainen, P., Paunola, E., Vartiainen, M.K. and Lappalainen, P. 2005. Actin-depolymerizing 
factor and cofi lin-1 play overlapping roles in promoting rapid F-actin depolymerization in 
mammalian non-muscle cells. Mol. Biol. Cell. 16:649-664.
Hotulainen, P. and Lappalainen, P. 2006. Stress fi bers are generated by two distinct actin assembly 
mechanisms in motile cells. J. Cell Biol. 173:383-394.
Hubberstey, A., Yu, G., Loewith, R., Lakusta, C. and Young, D. 1996. Mammalian CAP interacts 
with CAP, CAP2, and actin. J. Cell. Biochem. 60:459-466.
Hubberstey, A.V. and Mottillo, E.P. 2002. Cyclase-associated proteins: CAPacity for linking 
signal transduction and actin polymerization. FASEB J. 6:487-499.
Huckaba, T.M., Gay, A.C., Pantalena, L.F., Yang, H.C. and Pon, L.A. 2003. Live cell imaging 
of the assembly, disassembly, and actin cable-dependent movement of endosomes and and actin 
patches in the budding yeast, Saccharomyces serevisiae. J. Cell. Biol. 167:519-530.
Iida, K., Moriyma, K., Matsumoto, S., Kawasaki, H., Nishida, E. and Yahara, I. 1993. Isolation 
of yeast essential gene, COF1, that encodes a homologue of mammalian cofi lin, a low-Mr actin-
binding and depolymerizing protein. Gene. 124:115-120.
Ikeda, S., Cunningham, L.A., Boggess, D., Hawes, N., Hobson, C.D., Sundberg, J.P., Naggert, 
J.K., Smith, R.S. and Nishina, P.M. 2003. Aberrant actin cytoskeleton  leads to accelerated 
proliferation of corneal epithelial cells in mice defi cient for destrin (actin deolymerizing factor). 
Hum. Mol. Genet. 12(9):1029-1037. 
Kabsch, W. and Holmes, K.C. 1995. The actin fold. FASEB J. 9:167-174. 
Kabsch, W., Mannherz, D., Suck, D., Pai, E.F. and Holmes, K.C. 1990. Atomic structure of the 
actin:DNaseI complex. Nature. 347:37-44.
Kaksonen, M., Sun, Y. and Drubin, D.G. 2003. A pathway for association of receptors, adaptors, 
and actin during endocytic internalization. Cell. 115:475-87. 
Kaksonen, M., Toret, C.P. and Drubin, D.G. 2005. A modular design for the clathrin- and actin- 
mediated endocytosis machinery. Cell. 123:305-320.
Kawamukai, M., Gerst, J., Field, J., Riggs, M., Rodgers, L., Wigler, M. and Young, D. 1992. Genetic 
and biochemical analysis of the adenylyl cyclase-associated protein, cap, in Schizosaccharomyces 
pombe. Mol. Biol. Cell. 3:167-80.
Kilmartin, J. and Adams, A. 1984. Structural rearrangements of tubulin and actin during the cell 
cycle of Saccharomyces cerevisiae. J. Cell. Biol. 98:922-933. 
Krause, M., Dent, E.W., Bear, J.E., Loureiro, J.J. and Gertler, F.B. 2003. Ena/VASP proteins: 
regulators of the actin cytoskeleton and cell migration. Review. Annu. Rev. Cell Dev. Biol. 
19:541-64.
Ksiazek, D., Bandstetter, H., Israel, L., Bourenkov, G.P., Katchalova, G., Janssen, K.P., Bartunik, 
H.D., Noegel, A.A., Schleicher, M. and Holak, T. 2003. Structure of the N-terminal domain of the 




Kubler, E. and Riezman, H. 1993. Actin and fi mbrin are required for the internalization step of 
endocytosis in yeast. The EMBO J. 12:2855-2862.
Laing, N.G. 2007. Congenital myopathies. Review. Curr. Opin. Neurol. 20(5):583-9. 
Lambrech, A., Verschelde, J-L., Jonckheere, V., Goethals, M., Vandekerckhove, J. and Ampe, C. 
1997. The mammalian profi lin isoforms display complementary affi nities for PIP2 and proline 
rich sequences. The EMBO J. 3:484-494.
Lambrechts, A., Jonckheere, V., Dewitte, D., Vandekerckhove, J. and Ampe, C. 2002. Mutational 
analysis of human profi lin I reveals a second PI(4,5)-P2 binding site neighbouring the poly(L-
proline) binding site. BMC Biochem. 28;3:12.
Lappalainen, P. and Drubin, D.G. 1997. Cofi lin promotes rapid actin fi lament turnover in vivo. 
Nature. 388:78-82.
Lappalainen, P., Fedorov, E.V., Fedorov, A.A., Almo, S.C. and Drubin, D.G. 1997. Essential 
functions and actin-binding surfaces of yeast cofi lin revealed by systematic mutagenesis. EMBO 
J. 16:5520-5530.
Lappalainen, P., Kessels, M.M., Cope, M.J. and Drubin, D.G. 1998. The ADF homology (ADF-
H) domain: A highly exploited actin-binding module. Mol. Biol. Cell. 9:1951-1959.
Lassing, I. and Lindberg, U. 1985. Specifi c interaction between phosphatidyl 4,5-bisphosphate 
and profi lactin. Nature. 314:472-474.
Lazarides, E. and Lindberg, U. 1974. Actin is the naturally occurring inhibitor of 
deoxyribonuclease I. Proc. Natl. Acad. Sci. USA. 71(112):4742-4746.
Lila, T. and Drubin, D. 1997. Evidence for physical and functional interactions among two 
Saccharomyces cerevisiae SH3 domain proteins, an adenylyl cyclase-associated protein and the 
actin cytoskeleton. Mol. Biol. Cell. 8:367-385.
Lindberg, M.U. 1966. Crystallization from calf spleen of two inhibitors of deoxyribonuclease. J. 
Biol. Chem. 241(5):1246-1249. 
Lindberg, U., Schutt, C.E., Hellsten, E., Tjäder, A.C. and Hult, T. 1988. The use of poly(L-
proline)-sepharose in the isolation of profi lin and profi lactin complexes. Biochim. Biophys. Acta. 
967(3):391-400.
Lippincott, J. and Li, R. 1998. Sequential assembly of myosin II, an IQGAP-like protein, and 
fi lamentous actin to ring structure involved in budding yeast cytokinesis. J. Cell. Biol. 140: 355-
366.
Lu, J. and Pollard, T.D. 2001. Profi lin binding to poly-L-proline and actin monomers along with 
ability to catalyze actin nucleotide exchange is required for viability of fi ssion yeast. Mol. Biol. 
Cell. 12(4):1161-75. 
Maekawa, S., Nishida, E., Ohta, Y. and Sakai, H. 1984. Isolation of low molecular weight actin-
binding protein from porsine brain. J. Biochem. 95(2):377-385.
Magdolen, V., Oechsner, U., Müller, G. and Bandlow, W. 1988. The intron containing gene from 
yeast profi lin (PFY) encodes a vital function. Mol. Cell. Biol. 8:5108-5115. 
Mahoney, N.M., Janmey, P.A. and Almo, S.C. 1997. Structure of the profi lin-poly-L-proline 




Matsuzaki, F., Matsumoto, S., Yahara, I., Yonezawa, N., Nishida, E. and Sakai, H. 1988. Cloning 
and characterization of  porcine brain cofi lin cDNA. Cofi lin contains the nuclear transport signal 
sequence. J. Biol. Chem. 263(23):11564-11568.
Mattila, P.K., Quintero-Monzon, O., Kugler, J., Moseley, J.B., Almo, S.C., Lappalainen, P. and 
Goode, B.L. 2004. A high affi nity interaction with ADP-actin monomers underlies the mechanism 
and in vivo function of Srv2/cyclase-associated protein (CAP). Mol. Biol. Cell. 15:5158-5171.
Mattila, P.K., Pykäläinen, A., Saarikangas, J., Paavilainen, V.O., Vihinen, H., Jokitalo, E. and 
Lappalainen, P. 2007. Missing-in-metastasis and IRSp53 deform PI(4,5)P2-rich membranes by 
an inverse BAR domain-like mechanism. J. Cell Biol.176(7):953-64. 
Matviw, H., Yu, G. and Young, D. 1992. Identifi cation of a human cDNA encoding a protein that 
is structurally and functionally related to the yeast adenylyl cyclase-associated CAP proteins. 
Moll. Cell. Biol. 12(11):5033-5040.
Mavoungou, C., Israel, L., Rehm, T., Ksiazek, D., Krajewski, M., Popowicz, G., Noegel, A., 
Scleicher, M. and Holak, T.A. 2004. NMR structural characterization of the N-terminal domain of 
the adenylyl cyclase-associated protein (CAP) from Dictyostelium discoideum. J. Biomol. NMR. 
29:73-84.
McGough, A., Pope, B., Chiu, W. and Weeds, A. 1997. Cofi lin changes the twist of F-actin: 
implications for actin fi lament dynamics and cellular function. J. Cell Biol. 138:771-781.
McGough, A.M., Staiger, C.J., Min, J.G. and Simonetti, K.D. 2003. The gelsolin family of actin 
regulatory proteins: Modular structures, versatile functions. FEBS Lett. 552(2-3):75-81.
McKim, K.S., Matheson, C., Marra, M.A., Wakarchuk, M.F. and Baillie, D.L. 1994. The 
Caenorhabditis elegans unc-60 gene encodes proteins homologous to a family of actin-binding 
proteins. Mol. Gen. Genet. 242(3):346-57. 
Mockrin, S. C. and Korn, E. D. 1980. Acanthamoeba profi lin interacts with G-actin to increase 
the rate of exchange of actin-bound adenosine 5’-triphosphate. Biochemistry. 19:5359-5362.
Mogensen, J., Perrot, A., Andersen, P.S., Havndrup, O., Klausen, I.C., Christiansen, M., Bross, 
P., Egelblad, H., Bungaard, H., Osterziel, K.J., Haltern, G., Lapp, H., Reinecke, O., Gregersen, N. 
and Børglum, A.D. 2004. Clinical and genetic characteristics of α cardiac actin gene mutations in 
hypertrophic cardiomyopathy. J. Med. Genet. 41:e10.
Mohri, K. and Ono, S. 2003. Actin fi lament disassembling activity of Caenohabtidus elegans 
actin-interacting protein 1 (UNC-78) is dependent on fi lament binding by a specifi c ADF/cofi lin 
isoform. J. Cell. Sci. 116:4107-4118.
Moon, A.L., Janmey, P.A., Louie, K.A. and Drubin, D.G. 1993. Cofi lin is an essential component 
of the yeast cortical cytoskeleton. J. Cell Biol. 120:421-435.
Moraczewska, J., Wawro, B., Seguro, K. and Strzelecka-Golaszewska, H. 1999. Divalent cation-, 
nucleotide-, and polymerization-dependent changes in the conformation of subdomain 2 of actin. 
Biophys. J. 77(1):373-85. 
Moriyama, K. and Yahara, I. 2002. Human CAP1 is a key factor in the recycling of cofi lin and 
actin for rapid actin turnover. J. Cell Sci. 115:1591-601. 
Morrison, E.E. 2007. Action and interactions at microtubule ends. Review. Cell. Mol. Life Sci. 
64(3):307-17. 
Moseley, J. and Goode, B. 2006. Review. The actin cytoskeleton: from cellular functions to 
biochemical mechanism. Microbiol. Mol. Biol. Reviews. 17(3):605-645.
References
41
Mullins, R.D., Heuser, J.A. and Pollard, T.D. 1998. The interaction of Arp2/3 complex with actin: 
nucleation, high affi nity pointed end capping and formation of branching networks of fi laments. 
Proc. Natl. Acad. Sci. USA. 95:6181-6186.
Newpher, T.M., Smith, R.P., Lemmon, V. and Lemmon, S.K. 2005. In vivo dynamics of clathrin 
and its adaptor-dependent recruitment to the actin based endocytic machinery in yeast. Dev. Cell. 
9:87-98. 
Niggli, V. and Rossy, J. 2007. Ezrin/radixin/moesin: Versatile controllers of signaling molecules 
and of the cortical cytoskeleton. Int. J. Biochem. Cell Biol. Feb 22.
Nishida, Y., Shima, F., Sen, H., Tanaka, Y., Yanagihara, C., Yamawaki-Kataoka, Y., Kariya, K-
I. and Kataoka, T. 1998. Coiled-coil interaction of N-terminal 36 residus of cyclase-associated 
protein with adenylyl cyclase is suffi cient for it’s function in Saccharomyces cerevisiae Ras 
pathway. The J. Biol. Chem. 273:28019-28024.
Noegel, A.A., Rivero, F., Albrecht, R., Janssen, K-P., Köhler, J., Parent, C. and Schleicher, 
M. 1999. Assessing the role of ASP56/CAP homologue of Dictyostelium discoideum and 
requirements for subcellular localization. J. Cell. Sci. 112:3195-3203.
Noegel, A.A., Blau-Wasser, R., Sultana, H., Müller, R., Israel, L., Schleicher, M., Patel, H. and 
Weijer, C.J. 2004. The cyclase-associated protein CAP as regulator of cell polarity and cAMP 
signaling in Dictyostelium. Mol. Biol. Cell. 15:934-945.
Nogales, E. 1999. A structural view of microtubule dynamics. Review. Cell Mol. Life Sci. 1;56(1-
2):133-42. 
Nogales, E. and Wang, H.W. 2006. Structural mechanisms underlying nucleotide-dependent self-
assembly of tubulin and its relatives. Review. Curr. Opin. Struct. Biol. 16(2):221-9.
Oechsner, U., Magdolen, V. and Bandlow, W. 1987. The cDNA and deduced amino acid sequence 
of profi lin from  Saccharomyces cerevisiae. Nucleid Acid Res. 15:9078.
Ono S., Minami, N., Abe, H. and Obinata, T. 1994. Characterization of novel cofi lin isoform 
that is predominantly expressed in mammalian skeletal muscle. J. Biol. Chem. 269(21): 15280-
15286.
Paavilainen, V.O., Bertling, E., Falck, S. and Lappalainen, P. 2004. Regulation of cytoskeletal 
dynamics by actin monomer binding proteins. Review. Trends Cell Biol. 14:386-394. 
Paunola, E., Mattila, P. and Lappalainen, P. 2002. WH domain: a small, versatile adapter for actin 
monomers. Review. FEBS Letters. 513:92-97.
Peche, V., Shekar, S., Leichter, M., Korte, H., Schröder, R., Schleicher, M., Holak, T.A., Clemen, 
C.S., Ramanath-Y, B., Pfi tzer, G., Karakesisogglou, I. and Noegel, A.A. 2007. CAP2, cyclase-
associated protein 2, is a dual compartment protein. Cell. Mol. Life. Sci. 1-14.
Pelham, R.J. and Chang, F. 2001. Role of actin polymerization and actin cables in actin-patch 
movement in Schizosaccharomyces pombe. Nat. Cell. Biol. 3:235-244. 
Pellegrin, S. and Mellor, H. 2007. Actin stress fi bres. Review. J. Cell Sci. 120(Pt 20):3491-9. 
Perelroizen, I., Marchand, J.B., Blanchoin, L., Didry, D. and Carlier, M.F. 1994. Interaction of 
profi lin with G-actin and poly(L-proline). Biochemistry. 33:8472-8478.
Pollard T.D. 1986. Rate constants for the reactions of ATP- and ADP-actin with the ends of actin 
fi laments. J. Cell Biol. 103(6 Pt 2):2747-54. 
Pollard, T.D. and Borisy, G.G. 2003. Cellular motility driven by assembly and disassembly of 
actin fi laments. Cell. 112:453-465.
References
42
Pollard, T.D. and Weeds A.G., 1984. The rate constant for ATP hydrolysis by polymerized actin. 
FEBS Lett. 170(1):94-8. 
Pollard, T.D., Blanchoin, L. and Mullins, R.D. 2000. Molecular mechanisms controlling actin 
fi lament dynamics in nonmuscle cells. Annu. Rev. Bhiophys. Biomol. Struct. 29:545-576.
Popowicz, G.M., Schleicher, M., Noegel, A.A. and Holak, T.A. 2006. Filamins: promiscuous 
organizers of the cytoskeleton. Review. Trends Biochem. Sci. 31(7):411-9. 
Procaccio, V., Salazar, G., Ono, S., Styers, M., Gearing, M., Davila, A., Jimenez, R., Juncos, 
J., Gutekunst, C.-A., Meroni, G., Fontanella, B., Sontag, E., Sontag, J.M., Faundez, V. and 
Wainer, B.H. 2006. A Mutation of β-actin that alters depolymerization dynamics associated with 
autosomal dominant developmental malformations, deafness and dystonia. Am. J. Hum. Genet. 
78:947-960. 
Ressad, F., Didry, D., Xia, G.X., Hong, Y., Chua, N.H., Pantaloni, D. and Carlier, M.F. 1998. 
Kinetic analysis of the interaction of actin-depolymerizing factor (ADF)/cofi lin with G- and F-
actin. J. Biol. Chem. 273(33):20894-20902.
Rodal, A.A., Tetreault, J.W., Lappalainen, P., Drubin, D.G. and Amberg, D.C. 1999. Aip1p 
interacts with cofi lin to disassemble actin fi laments. J.Cell. Biol. 145:1251-1264.
Schafer, D.A., Korshunova, Y.O., Schroer, T.A. and Cooper, J.A. 1994. Differential localization 
and sequence analysis of capping protein beta-subunit isoforms of vertebrates. J. Cell Biol. 
127:453-465.
Schirenbeck, A., Bretschneider, R., Arasada, M., Schleicher, M. and Faix, J. 2005. The 
diaphanous-related forming dDia2 is reguired for the formation and maintenance of fi lopodia. 
Nat. Cell. Biol. 7:619-625. 
Schott, D.H., Collins, R.N. and Bretscher, A. 2002. Secretory vesicle transport velocity  in living 
cell depends on the myosin-V lever arm length. J. Cell. Biol. 156:35-39.
Schüler, H. 2001. ATPase activity and conformational changes in the regulation of the actin. 
Biochim. Biophys. Acta. 1549(2):137-147.
Schutt, C.E., Myslik, J.C., Rozycki, M.D., Goonesekere, N.C. and Lindberg, U. 1993. The 
structure of crystalline profi lin-beta-actin. Nature. 365(6449):810-816.
Sellers, J.R. 2000. Myosins: A diverse superfamily. Biochim. Biophys. Acta. 1496(1):3-22.
Shibata, R., Mori, T., Du, W., Chuma, M., Gotoh, M., Shimazu, M., Uada, M., Hirohashi, 
S. and Sakamoto, M. 2006. Overexpression of cyclase-associated protein 2 in multistage 
hepatocarsinogenesis. Clin. Cancer Res. 12(18)5363-5368.
Shima, F., Okada, T., Kido, M., Sen, H., Tanaka, Y., Tamada, M., Hu, C-D., Yamawaki-kataoka, 
Y., Kariya, K-I. and Kataoka, T. 2000. Association of yeast adenylyl cyclase with cyclase-
associated protein CAP forms a second Ras-binding site which mediates its Ras-dependent 
activation. Mol. Cell. Biol. 20(1):26-33  
Shortle, D., Haber, J. and Botstein, D. 1982. Lethal distruption of yeast actin gene by integrative 
DNA transformation. Science. 217:371-373.
Skare, P. and Karlsson, R. 2002. Evidence for two interaction regions for phosphatidylinositol(4,5)-
bisphosphate on mammalian profi lin I. FEBS lett. 522:119-24. 
Sparrow, J.C., Nowak, K.J., Durling, H.J., Beggs, A.H., Wallgren-Pettersson, C., Romero, N., 
Nonaka, I. and Laing, N.G. 2003. Muscle disease caused by mutations in the skeletal muscle 
alpha-actin gene (ACT1). Review. Neuromuscular Disorders. 13:519-531.
References
43
Strelkov, S.V., Herrmann, H. and Aebi, U. 2003. Molecular architecture of intermediate fi laments. 
Review. Bioessays. 25(3):243-51.
Suetsugu, S., Miki, H. and Takenawa, T. 1998. The essential role of profi lin in the assembly of 
actin for microspike formation. EMBO J. 17(22):6516-6526. 
Sultana, H., Rivero, F., Blau-Wasser, R., Schwager, S., Balbo, A., Bozzaro, S., Schleicher, M. and 
Noegel, A.A. Cyclase-associated protein is essential for the functioning of the endo-lysosomal 
system and provides a link to the actin cytoskeleton. Traffi c. 6:930-946.
Svitkina, T.M and Borisy, G.G. 1999. Arp2/3 complex and actin depolymerizing factor/cofi lin 
in dendritic organization and treadmilling of actin fi lament array in lamellipodia. J. Cell. Biol. 
145:1009-1026.
Swiston, J., Hubberstey, A., Yu, G. and Young, D. 1995. Differential expresson of CAP and CAP2 
in adult rat tissues. Gene. 165:273-277.
Toivola, D.M., Tao, G.Z., Habtezion, A., Liao, J. and Omary, M.B. 2005. Cellular integrity plus: 
organelle-related and protein-targeting functions of intermediate fi laments. Review. Trends Cell 
Biol. 15(11):608-17. 
Valenta, R., Duchene, M., Ebner, C., Valent, P., Sillaber, C., Deviller, P., Ferreira, F., Tejkl, M., 
Edelmann, H. and Kraft, D. 1992. Profi lins constitute a novel family of functional plant pan-
allergens. J. Exp. Med. 175(2):377-385.
Vandekerckhove, J. and Weber, K. 1978. At least six different actins are expressed in a higher 
mammal: an analysis based on the amino acid sequence of the amino-terminal tryptic peptide. J. 
Mol. Biol. 25:783-802. 
Vartiainen, M.K., Mustonen, T., Mattila, P.K., Ojala, O.J., Thesleff, I., Partanen, J. and 
Lappalainen, P. 2002. The three mouse actin-depolymerizing factor/cofi lins evolved to fulfi ll 
cell-type-specifi c requirements for actin dynamics. Mol. Biol. Cell. 13(1):183-94.
Vartiainen, M., Ojala, P.J., Auvinen, P., Peränen, J. and Lappalainen, P. 2000. Mouse A6/twinfi lin 
is an actin monomer-binding protein that localizes to the regions of rapid actin dynamics. Mol. 
Cell Biol. 20:1772-1783.
Vartiainen, M.K., Sarkkinen, E.M., Matilainen, T., Salminen, M. and Lappalainen, P. 2003. 
Mammals have two twinfi lin isoforms whose subcellular localizations and tissue distributions 
are differentially regulated. J. Biol. Chem. 278:34347-34355.
Vavylonis, D., Kovar, D., O’shaughnessy, B. and Pollard, T.D. 2006. Model of formin-associated 
actin fi lament elongation. Mol. Cell 21:455-466.
Vojtek, A.B. and Cooper, J.A. 1993. Identifi cation of a cDNA encoding mouse CAP: a homolog 
of the yeast adenylyl cyclase associated protein. J. Cell Sci. 105:777-785.
Vojtek, A., Haarer, B., Field, J., Gerst, J., Pollard, T. D., Brown, S. and Wigler, M. 1991. Evidence 
for a functional link between profi lin and CAP in the yeast S. cerevisiae. Cell. 66:497-505.
Wade, R.H. and Hyman, A.A. 1997. Microtubule structure and dynamics. Review. Curr. Opin. 
Cell Biol. 9(1):12-7.
Wang, J., Suzuki, N. and Kataoka, T. 1995. The 70-kilodalton adenylyl cyclas-associated protein 
is not essential for interaction of Saccharomyces cerevisiae adenylyl cyclase with RAS proteins. 
Mol. Cell. Biol. 12(11):4937-494.
Watanabe, T., Noritake, J. and Kaibuchi, K. 2005. Regulation of microtubules in cell migration. 
Review. Trends Cell Biol. 15(2):76-83. 
References
44
Watts, F.Z., Shieks, G. and Orr, E. 1987. The yeast MYO1 gene encoding a myosin-like protein 
required for cell division. EMBO J. 6:3499-3505.
Wear, M.A., Yamashita, A., Kim, K., Maeda, Y. and Cooper, J.A. 2003. How capping protein 
binds the barbed end of the actin fi lament. Curr Biol. 13(17):1531-7. 
Westermann, S. and Weber, K. 2003. Post-translational modifi cations regulate microtubule 
function. Review. Nat. Rev. Mol. Cell Biol. 4(12):938-47. 
Wegner, A. 1982. Treadmilling of actin at physiological salt concentrations. An analysis of the 
critical concentrations of actin fi laments. J. Mol. Biol. 161(4):607-15.
Winter, D.C., Choe, E.Y. and Li, R. 1999. Genetic dissection of the budding yeast Arp2/3 
complex: a comparison of the in vivo and structural roles of individual subunits. Proc. Natl. Acad. 
Sci. USA. 96:7288.7293.
Witke, W., Sutherland, J.D. and Sharpe, A. 2001. Profi lin I is essential for cell survival and cell 
division in early mouse development. Proc. Natl. Acad. Sci. USA. 98(7):3832-3836. 
Witke, W. 2004. The role of profi lin complexes in cell motility and other cellular processes. 
Review. Trends in Cell Biol. 14:461-468.
Wolven, A.K., Belmont, L.D., Mahoney, N.M., Almo, S.C. and Drubin, D.G. 2000. In vivo 
importance of actin nucleotide exchange catalyzed by profi lin. J. Cell Biol. 150:895-904.
Wriggers, W., Tang, J.X., Azuma, T., Marks, P.V. and Janmey, P. 1998. Cofi lin and gelsolin 
segment-1: molecular dynamics simulation and biochemical analysis predict a similar actin 
binding mode. J. Mol. Biol. 282:921-932. 
Yoon, Y., Pitts, K. and McNiven, M. 2002. Studying cytoskeletal dynamics in living cells using 
green fl uorescent protein. Review. Mol. Biotechnol. 21(3):241-50. 
Yonezawa, N., Homma, Y., Yahara, I., Sakai, H. and Nishida, E. 1991. A short sequence 
responsible for both phosphoinositide binding and actin binding activities of cofi lin. J. Biol. 
Chem. 266:17218-17221.
Yonezawa, N., Nishida, E., Koyasu, S., Maekawa, S., Ohta, Y., Yahara, I. and Sakai, H. 1987. 
Distribution among tissues and intracellular localization of cofi lin, a 21 kDa actin-binding protein. 
Cell Struct. Funct. 12:443-452.
Yusof, A., Hu, N.-J., Wlodawer, A. and Hofmann, A. 2005. Structural evidence for variable 
oligomerization of the N-terminal domain of cyclase-associated protein (CAP). Proteins: 
Structure, Function, and Bioinformatics. 58:255-262.
Yusof, A., Jaenicke, E., Pedersen, J.S., Noegel, A.A., Schleicher, M. and Hofmann, A. 2006. 
Mechanism of oligomerisation of cyclase-associated protein from Dictyostelium discoideum in 
solution. J. Mol. Biol. 362:1072-1081.
Yu, G., Swiston, J. and Young, D. 1994. Comparison of human CAP1 and CAP2, homologs of 
the yeast adenylyl cyclase-associated proteins. J. Cell Sci. 107:1671-1678.
Yu, J., Wang, C., Palmieri, S.J., Haarer, B.K. and Field, J. 1999. A cytoskeletal localizing domain 
in the cyclase-associated protein, CAP/Srv2p, regulates access to a distant SH3-binding site. J. 
Biol. Chem. 274:19985-19991.
Zelicof, A., Gatica, J. and Gerst, J.E. 1999. Molecular cloning and characterization of rat homolog 
of CAP, The adenylyl cyclase-associated protein from Saccharomyces serevisiae. J. Biol. Chem. 
268(18):13448-13453. 
References
